<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1387" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1387/" /><meta name="ncbi_pagename" content="Chorea-Acanthocytosis - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Chorea-Acanthocytosis - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Chorea-Acanthocytosis" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/04/18" /><meta name="citation_author" content="Antonio Velayos Baeza" /><meta name="citation_author" content="Carol Dobson-Stone" /><meta name="citation_author" content="Luca Rampoldi" /><meta name="citation_author" content="Benedikt Bader" /><meta name="citation_author" content="Ruth H Walker" /><meta name="citation_author" content="Adrian Danek" /><meta name="citation_author" content="Anthony P Monaco" /><meta name="citation_pmid" content="20301561" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1387/" /><meta name="citation_keywords" content="ChAc" /><meta name="citation_keywords" content="Choreoacanthocytosis" /><meta name="citation_keywords" content="ChAc" /><meta name="citation_keywords" content="Choreoacanthocytosis" /><meta name="citation_keywords" content="Vacuolar protein sorting-associated protein 13A" /><meta name="citation_keywords" content="VPS13A" /><meta name="citation_keywords" content="Chorea-acanthocytosis" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Chorea-Acanthocytosis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Antonio Velayos Baeza" /><meta name="DC.Contributor" content="Carol Dobson-Stone" /><meta name="DC.Contributor" content="Luca Rampoldi" /><meta name="DC.Contributor" content="Benedikt Bader" /><meta name="DC.Contributor" content="Ruth H Walker" /><meta name="DC.Contributor" content="Adrian Danek" /><meta name="DC.Contributor" content="Anthony P Monaco" /><meta name="DC.Date" content="2019/04/18" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1387/" /><meta name="description" content="Chorea-acanthocytosis (ChAc) is characterized by a progressive movement disorder, cognitive and behavior changes, a myopathy that can be subclinical, and chronic hyperCKemia in serum. Although the disorder is named for acanthocytosis of the red blood cells, this feature is variable. The movement disorder is mostly limb chorea, but some individuals present with parkinsonism. Dystonia is common and affects the oral region and especially the tongue, causing dysarthria and serious dysphagia with resultant weight loss. Habitual tongue and lip biting are characteristic, as well as tongue protrusion dystonia. Progressive cognitive and behavioral changes resemble those in a frontal lobe syndrome. Seizures are observed in almost half of affected individuals and can be the initial manifestation. Myopathy results in progressive distal muscle wasting and weakness. Mean age of onset in ChAc is about 30 years, although ChAc can develop as early as the first decade or as late as the seventh decade. It runs a chronic progressive course and may lead to major disability within a few years. Life expectancy is reduced, with age of death ranging from 28 to 61 years." /><meta name="og:title" content="Chorea-Acanthocytosis" /><meta name="og:type" content="book" /><meta name="og:description" content="Chorea-acanthocytosis (ChAc) is characterized by a progressive movement disorder, cognitive and behavior changes, a myopathy that can be subclinical, and chronic hyperCKemia in serum. Although the disorder is named for acanthocytosis of the red blood cells, this feature is variable. The movement disorder is mostly limb chorea, but some individuals present with parkinsonism. Dystonia is common and affects the oral region and especially the tongue, causing dysarthria and serious dysphagia with resultant weight loss. Habitual tongue and lip biting are characteristic, as well as tongue protrusion dystonia. Progressive cognitive and behavioral changes resemble those in a frontal lobe syndrome. Seizures are observed in almost half of affected individuals and can be the initial manifestation. Myopathy results in progressive distal muscle wasting and weakness. Mean age of onset in ChAc is about 30 years, although ChAc can develop as early as the first decade or as late as the seventh decade. It runs a chronic progressive course and may lead to major disability within a few years. Life expectancy is reduced, with age of death ranging from 28 to 61 years." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1387/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/chac/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1387/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D62DFE040392100000000042A0155.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1387_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1387_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/x-dcdp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/choroid/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1387_"><span class="title" itemprop="name">Chorea-Acanthocytosis</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: ChAc, Choreoacanthocytosis</div><p class="contrib-group"><span itemprop="author">Antonio Velayos Baeza</span>, PhD, <span itemprop="author">Carol Dobson-Stone</span>, DPhil, <span itemprop="author">Luca Rampoldi</span>, PhD, <span itemprop="author">Benedikt Bader</span>, MD, <span itemprop="author">Ruth H Walker</span>, MB, ChB, PhD, <span itemprop="author">Adrian Danek</span>, MD, and <span itemprop="author">Anthony P Monaco</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1387_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1387_ai__"><div class="contrib half_rhythm"><span itemprop="author">Antonio Velayos Baeza</span>, PhD<div class="affiliation small">Neurogenetics Group<br />Wellcome Trust Centre for Human Genetics<br />Oxford, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.xo.llew@soyaleva" class="oemail">ku.ca.xo.llew@soyaleva</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Carol Dobson-Stone</span>, DPhil<div class="affiliation small">Neuroscience Research Australia and University of New South Wales<br />Sydney, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.ude.aruen@enots-nosbod.c" class="oemail">ua.ude.aruen@enots-nosbod.c</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Luca Rampoldi</span>, PhD<div class="affiliation small">Division of Genetics and Cell Biology<br />San Raffaele Scientific Institute<br />Milan, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.rsh@acul.idlopmar" class="oemail">ti.rsh@acul.idlopmar</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Benedikt Bader</span>, MD<div class="affiliation small">Neurologische Klinik<br />Ludwig-Maximilians-Universit&#x000e4;t<br />Munich, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.nehcneum-inu.dem@redab.tkideneb" class="oemail">ed.nehcneum-inu.dem@redab.tkideneb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ruth H Walker</span>, MB, ChB, PhD<div class="affiliation small">Department of Neurology<br />James J Peters Veterans Affairs Medical Center<br />Mount Sinai School of Medicine<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mssm@reklaw.htur" class="oemail">ude.mssm@reklaw.htur</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Adrian Danek</span>, MD<div class="affiliation small">Neurologische Klinik<br />Ludwig-Maximilians-Universit&#x000e4;t<br />Munich, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.nehcneum-inu.dem@kenad.nairda" class="oemail">ed.nehcneum-inu.dem@kenad.nairda</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Anthony P Monaco</span>, MD, PhD<div class="affiliation small">Neurogenetics Group<br />Wellcome Trust Centre for Human Genetics<br />Oxford, United Kingdom</div><div class="affiliation small">President, Tufts University<br />Medford, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.xo.llew@ocanom.ynohtna" class="oemail">ku.ca.xo.llew@ocanom.ynohtna</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ude.stfut@ocanom.ynohtna" class="oemail">ude.stfut@ocanom.ynohtna</a><div></div></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 14, 2002</span>; Last Revision: <span itemprop="dateModified">April 18, 2019</span>.</p><p><em>Estimated reading time: 31 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="chac.Summary" itemprop="description"><h2 id="_chac_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Chorea-acanthocytosis (ChAc) is characterized by a progressive movement disorder, cognitive and behavior changes, a myopathy that can be subclinical, and chronic hyperCKemia in serum. Although the disorder is named for acanthocytosis of the red blood cells, this feature is variable. The movement disorder is mostly limb chorea, but some individuals present with parkinsonism. Dystonia is common and affects the oral region and especially the tongue, causing dysarthria and serious dysphagia with resultant weight loss. Habitual tongue and lip biting are characteristic, as well as tongue protrusion dystonia. Progressive cognitive and behavioral changes resemble those in a frontal lobe syndrome. Seizures are observed in almost half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and can be the initial manifestation. Myopathy results in progressive distal muscle wasting and weakness. Mean age of onset in ChAc is about 30 years, although ChAc can develop as early as the first decade or as late as the seventh decade. It runs a chronic progressive course and may lead to major disability within a few years. Life expectancy is reduced, with age of death ranging from 28 to 61 years.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of ChAc is based primarily on clinical findings, the presence of characteristic MRI findings, and evidence of muscle disease. CT and MRI reveal atrophy of the caudate nuclei with dilatation of the anterior horns of the lateral ventricles. MRI commonly shows T<sub>2</sub>-weighted signal increase in the caudate and putamen. Acanthocytes are present in 5%-50% of the red cell population. In some cases, acanthocytosis may be absent or may appear only late in the course of the disease. Increased serum concentration of muscle creatine kinase (CK) is observed in the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Muscle biopsy reveals central nuclei and atrophic fibers. <i>VPS13A,</i> which encodes chorein, is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is currently known to cause ChAc.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is purely symptomatic, and may include: botulinum toxin for decreasing the oro-facio-lingual dystonia; feeding assistance; speech therapy; mechanical protective devices; splints for foot drop; phenytoin, clobazam, valproate, and levetiracetam for seizure management; antidepressant or antipsychotic medications; dopamine antagonists/depleters such as atypical neuroleptics or tetrabenazine; deep brain stimulation may be helpful in selected cases.</p><p><i>Surveillance:</i> Monitoring of nutritional status and adaptation of diet to assure adequate caloric intake and to prevent aspiration; EEG every third year.</p><p><i>Agents/circumstances to avoid:</i> Seizure-provoking circumstances and anticonvulsants that may worsen involuntary movements.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ChAc is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives is possible if the pathogenic variants in the family are known. Prenatal testing is possible for families in which the pathogenic variants are known.</p></div></div><div id="chac.Diagnosis"><h2 id="_chac_Diagnosis_">Diagnosis</h2><div id="chac.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>Chorea-acanthocytosis (ChAc) can be diagnosed with high certainty on clinical grounds alone; no formal criteria or obligatory findings have been established. However, since every <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual does not exhibit the classic syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> or protein-based testing can be used to confirm the diagnosis.</p><ul><li class="half_rhythm"><div>The movement disorder is mostly chorea, but some individuals present with a parkinsonian syndrome. Dystonia is common and affects the oral region and the tongue in particular. Characteristic unintended tongue protrusion, feeding dystonia and habitual tongue and lip biting cause dysarthria and serious dysphagia with resultant weight loss [<a class="bk_pop" href="#chac.REF.bader.2010.127">Bader et al 2010</a>]. The movement disorder is progressive.</div></li><li class="half_rhythm"><div>Progressive cognitive and behavioral changes resemble a frontal lobe syndrome (i.e., loss of social inhibition and executive functions) [<a class="bk_pop" href="#chac.REF.walterfang.2008.422">Walterfang et al 2008</a>].</div></li><li class="half_rhythm"><div>Seizures, observed in almost half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, can be the initial manifestation [<a class="bk_pop" href="#chac.REF.rampoldi.2002.475">Rampoldi et al 2002</a>]. Seizures mostly originate from the temporal lobes; thus, affected individuals can present with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> temporal lobe epilepsy [<a class="bk_pop" href="#chac.REF.scheid.2009.1419">Scheid et al 2009</a>].</div></li><li class="half_rhythm"><div>The myopathy is progressive and characterized by distal muscle wasting and weakness, but may remain subclinical. Depression of deep tendon reflexes and vibration sense are common, resulting from an axonal neuropathy that contributes to the observed amyotrophy. The pyramidal tracts are not involved and the plantar reflexes are flexor.</div></li><li class="half_rhythm"><div>Subtle eye movement abnormalities, e.g., impaired upgaze or slowed saccades, may be found. The retina is normal. While retinal detachment has been reported in two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from the same family, it is not clear that the retinal detachment was caused by ChAc [<a class="bk_pop" href="#chac.REF.ogawa.2013.913">Ogawa et al 2013</a>].</div></li></ul><p><b>Neuroimaging.</b> CT and MRI reveal atrophy of the caudate nuclei with dilatation of the anterior horns of the lateral ventricles [<a class="bk_pop" href="#chac.REF.gradstein.2005.1979">Gradstein et al 2005</a>]. The caudate nucleus and putamen show significant and marked reductions in volume compared with controls [<a class="bk_pop" href="#chac.REF.walterfang.2011b.29">Walterfang et al 2011b</a>]. There may be slight generalized cerebral cortical atrophy; frontal lobe atrophy has also been reported [<a class="bk_pop" href="#chac.REF.neutel.2012.293">Neutel et al 2012</a>]. The extent of basal ganglia atrophy is best appreciated on sections in the frontal plane. MRI may show T<sub>2</sub>-weighted signal increase in the caudate and putamen, and may occasionally demonstrate iron deposition [<a class="bk_pop" href="#chac.REF.lee.2011.321">Lee et al 2011</a>, <a class="bk_pop" href="#chac.REF.kaul.2013.169">Kaul et al 2013</a>]. Hippocampal sclerosis and atrophy are also seen frequently [<a class="bk_pop" href="#chac.REF.alasmi.2005.1256">Al-Asmi et al 2005</a>, <a class="bk_pop" href="#chac.REF.huppertz.2008.1393">Huppertz et al 2008</a>, <a class="bk_pop" href="#chac.REF.scheid.2009.1419">Scheid et al 2009</a>].</p><p><b>Muscle and liver enzymes.</b> Increased serum concentration of muscle CK is observed in the majority of individuals. Less commonly, the serum concentrations of LDH, AST, and ALT are increased.</p><p><b>Electrophysiologic tests</b> demonstrate a sensory axonopathy with normal nerve conduction velocities and reduced sensory action potentials [<a class="bk_pop" href="#chac.REF.rampoldi.2002.475">Rampoldi et al 2002</a>]. Electromyography commonly reveals neurogenic changes.</p></div><div id="chac.Testing"><h3>Testing</h3><p><b>Acanthocytosis.</b> Acanthocytes are found in the blood of individuals with ChAc in a highly variable proportion, usually 5%-50% of the red cell population. In some cases, acanthocytosis may be absent [<a class="bk_pop" href="#chac.REF.bayreuther.2010.100">Bayreuther et al 2010</a>] or may appear only late in the course of the disease [<a class="bk_pop" href="#chac.REF.sorrentino.1999.175">Sorrentino et al 1999</a>]. The proportion of acanthocytes does not correlate with disease severity.</p><ul><li class="half_rhythm"><div>Scanning electron microscopy of erythrocytes fixed with glutaraldehyde is probably the most reliable method of detecting acanthocytes, but is not routinely available.</div></li><li class="half_rhythm"><div>A general standard for the determination of acanthocytosis has been proposed. Blood is diluted 1:1 with 0.9% saline and 10 U/mL heparin, and examined using phase-contrast microscopy after 30 minutes' incubation in a shaker. In normal samples, fewer than 6.3% of cells are spiculated [<a class="bk_pop" href="#chac.REF.storch.2005.84">Storch et al 2005</a>]. (Dry blood smears are often inadequate.)</div></li></ul><p><b>Chorein detection.</b> Western blot analysis revealed absence or marked reduction of chorein, the protein encoded by <i>VPS13A</i>, in erythrocytes from individuals with ChAc. In contrast, normal levels of chorein were observed in samples from individuals with <a href="/books/n/gene/mcleod/">McLeod syndrome</a> and <a href="/books/n/gene/huntington/">Huntington disease</a>, suggesting that loss of full-length chorein is diagnostic of ChAc [<a class="bk_pop" href="#chac.REF.dobsonstone.2004.299">Dobson-Stone et al 2004</a>]. Testing is available on a research basis (see <a href="#chac.Author_Notes">Author Notes</a>) and is convenient for screening purposes. Of note, normal levels of chorein are theoretically possible for some <i>VPS13A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> alleles (e.g., some <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> substitutions); therefore, presence of normal levels of chorein does not exclude the diagnosis of ChAc.</p><div id="chac.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>VPS13A</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are currently known to cause ChAc.</p><div id="chac.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Chorea-Acanthocytosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1387/table/chac.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chac.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_chac.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_chac.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_chac.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_chac.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>VPS13A</i></td><td headers="hd_h_chac.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_chac.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_chac.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_chac.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="chac.TF.1.1"><p class="no_margin">See <a href="/books/NBK1387/#chac.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#chac.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="chac.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected unless they are in homozygosis. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="chac.TF.1.3"><p class="no_margin">Mutations are dispersed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (see <a href="#chac.Molecular_Genetics">Molecular Genetics</a>).</p></div></dd><dt>4. </dt><dd><div id="chac.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="chac.TF.1.5"><p class="no_margin">Homozygous intragenic deletions spanning one or more exons have been described; see <a href="#chac.Molecular_Genetics">Molecular Genetics</a>. Many such deletions will not be amplified by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> [<a class="bk_pop" href="#chac.REF.dobsonstone.2005.151">Dobson-Stone et al 2005</a>].</p></div></dd></dl></div></div></div></div></div><div id="chac.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">When clinical findings suggest the diagnosis of ChAc, the initial step is to evaluate the individual for elevated levels of serum creatine kinase (CK) and liver enzymes.</p></dd><dt>2.</dt><dd><p class="no_top_margin">If these tests support the diagnosis of ChAc, <a href="/books/n/gene/mcleod/">McLeod syndrome</a> (see <a href="#chac.Differential_Diagnosis">Differential Diagnosis</a>) should be excluded by detailed characterization of Kell antigen expression on red blood cells (request exclusion of "McLeod <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>").</p></dd><dt>3.</dt><dd><p class="no_top_margin">If a diagnosis of ChAc is further supported, western blot screening test may be carried out.</p></dd><dt>4.</dt><dd><p class="no_top_margin">In case of doubt or negative diagnosis by western blot, but strongly suggestive clinical findings, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>VPS13A</i> should be considered.</p></dd></dl></div></div><div id="chac.Clinical_Characteristics"><h2 id="_chac_Clinical_Characteristics_">Clinical Characteristics</h2><div id="chac.Clinical_Description"><h3>Clinical Description</h3><p>Mean age of onset in chorea-acanthocytosis (ChAc) is about age 30 years, although ChAc can develop as early as the first decade or as late as the seventh decade. It runs a chronic progressive course and may lead to major disability within a few years. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are bedridden or wheelchair dependent by the third decade [<a class="bk_pop" href="#chac.REF.aasly.1999.322">Aasly et al 1999</a>]. Life expectancy is reduced and several instances of sudden unexplained death or death during epileptic seizures have been reported. Age at death ranges from 28 to 61 years.</p><p><b>Movement disorder.</b> Limb chorea is the most common movement disorder in individuals with ChAc. Flinging arm and leg movements, shoulder shrugs, and pelvic thrusts are common. An unsteadiness of stance and gait, often with falls, seems to have choreiform as well as dystonic components. Ambulation may be severely impaired. Violent trunk spasms may occur with sudden flexion or extension movements, the latter causing head drop and head banging with a risk of head and neck injury [<a class="bk_pop" href="#chac.REF.schneider.2010.1487">Schneider et al 2010</a>]. Impaired postural reflexes may result in falls, as may sudden buckling of knees and equinovarus foot deformity, the latter related to dystonia as well as atrophy of the peroneal muscles. Degenerative arthritis due to hyperkinetic movement has been reported, requiring surgical joint replacement [<a class="bk_pop" href="#chac.REF.stafford.2013">Stafford et al 2013</a>].</p><p>Most characteristic of ChAc are the involuntary movements that affect face, mouth, tongue, pharynx, and larynx. Involuntary vocalizations (vocal tics) are present in about two thirds of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#chac.REF.saiki.2004.833">Saiki et al 2004</a>]. A variety of vocalizations have been described. These may consist of clicking, gasping, sighing, whistling, blowing, sucking, grunting noises, perseveration of word elements or phrases, and continuous humming. There may be habitual teeth grinding (bruxism), spitting, or involuntary belching [<a class="bk_pop" href="#chac.REF.wihl.2001.572">Wihl et al 2001</a>, <a class="bk_pop" href="#chac.REF.sibon.2004.856">Sibon et al 2004</a>]. Continuous tongue and lip biting can lead to mutilation, which affected individuals typically try to avoid by keeping an object such as a handkerchief between the teeth, which may function either as a sensory trick to reduce dystonia or as a mechanical obstacle.</p><p>Swallowing is often impaired in the oral phase (while pharyngeal and esophageal phases of swallowing seem to be intact), resulting in dysphagia with reduced caloric intake and potentially severe weight loss. Action-induced protrusion dystonia of the tongue while feeding is typical and causes the tongue to push the food out of the mouth [<a class="bk_pop" href="#chac.REF.bader.2010.127">Bader et al 2010</a>]. Abnormal swallowing causes drooling.</p><p>Dysarthria is common; slurred speech may be a presenting symptom. In the course of ChAc, communication may become limited to grunting or whispering, and individuals may become mute and dependent on computer-based speech aids [<a class="bk_pop" href="#chac.REF.aasly.1999.322">Aasly et al 1999</a>].</p><p>As the hyperkinetic orofacial state progresses to mutism, the choreiform and dystonic syndrome gradually evolves into parkinsonism in about one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Increased muscle tone, rest tremor, impaired postural reflexes, bradykinesia, facial masking, and micrographia may appear. Parkinsonism has occasionally been reported as the presenting symptom of ChAc [<a class="bk_pop" href="#chac.REF.bostantjopoulou.2000.1271">Bostantjopoulou et al 2000</a>].</p><p>In a few cases, ocular motor abnormalities have been noted, with apraxia of lid opening, intermittent blepharospasm, frequent square wave jerks, slowing of saccades (mainly vertical), and reduced saccadic range [<a class="bk_pop" href="#chac.REF.gradstein.2005.1979">Gradstein et al 2005</a>].</p><p><b>Behavior changes.</b> Changes in personality and behavior along with psychopathologic abnormalities occur in about two thirds of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#chac.REF.danek.2004">Danek et al 2004</a>]. Apathy, depression, and bradyphrenia (slowness of thought) can be seen, but hyperactivity, irritability, distractibility, and emotional instability can also be observed. Individuals may behave in an immature or disinhibited manner that includes sexual disinhibition. They may show obsessive-compulsive behavior including trichotillomania [<a class="bk_pop" href="#chac.REF.lossos.2005.611">Lossos et al 2005</a>, <a class="bk_pop" href="#chac.REF.walterfang.2008.422">Walterfang et al 2008</a>] and self-inflicted chronic excoriations on the head [<a class="bk_pop" href="#chac.REF.walker.2006.2268">Walker et al 2006</a>]. Loss of insight, self-neglect, anxiety, paranoia, aggression against others, and autoaggression are observed. Suicide and suicidal ideation are part of the disease spectrum [<a class="bk_pop" href="#chac.REF.sorrentino.1999.175">Sorrentino et al 1999</a>]. Disruptions to key frontostriatal loops secondary to pathology in the striatum and pallidum appear to predispose individuals to major neuropsychiatric conditions [<a class="bk_pop" href="#chac.REF.walterfang.2011a.1275">Walterfang et al 2011a</a>].</p><p><b>Cognitive changes.</b> Cognitive deterioration is common. Memory and executive functions, such as the ability to sustain concentration over time, planning and modifying behavior, seem particularly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. These findings resemble those in the frontal lobe syndrome observed in frontotemporal dementia [<a class="bk_pop" href="#chac.REF.danek.2004">Danek et al 2004</a>], but may also be associated with temporal lobe epilepsy [<a class="bk_pop" href="#chac.REF.bader.2011.340">Bader et al 2011</a>]. <a class="bk_pop" href="#chac.REF.walterfang.2011b.29">Walterfang et al [2011b]</a> suggested that dorsal striatal neuron loss may occur early in the disease process, correlating with early neuropsychiatric and cognitive presentations of the disease, and subsequently follow a dorsal-ventral gradient.</p><p><b>Seizures.</b> Epilepsy is observed in almost half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and can be the initial manifestation [<a class="bk_pop" href="#chac.REF.alasmi.2005.1256">Al-Asmi et al 2005</a>]. It is usually manifested as grand mal seizures and is probably secondarily generalized, for example, from temporal lobe foci [<a class="bk_pop" href="#chac.REF.scheid.2009.1419">Scheid et al 2009</a>, <a class="bk_pop" href="#chac.REF.bader.2011.340">Bader et al 2011</a>]. There may be prolonged states of memory impairment and confusion most likely corresponding to non-convulsive seizures [<a class="bk_pop" href="#chac.REF.bader.2011.340">Bader et al 2011</a>].</p><p><b>Neuropathy and myopathy.</b> Nerve and muscle involvement causes ankle areflexia in almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and muscle atrophy and weakness in at least half. Symptoms consistent with a neuromuscular syndrome suggestive of motor neuron disease have been reported [<a class="bk_pop" href="#chac.REF.miki.2010.271">Miki et al 2010</a>, <a class="bk_pop" href="#chac.REF.neutel.2012.293">Neutel et al 2012</a>]. Sensory loss is usually slight or may only be detected as reduced vibration sense.</p><p><b>Cardiomyopathy</b> (e.g., of the dilated type [<a class="bk_pop" href="#chac.REF.kageyama.2000.816">Kageyama et al 2000</a>, <a class="bk_pop" href="#chac.REF.kageyama.2007.1669">Kageyama et al 2007</a>]) may occur but is uncommon, in clear contrast to <a href="/books/n/gene/mcleod/">McLeod syndrome</a> (see <a href="#chac.Differential_Diagnosis">Differential Diagnosis</a>) [<a class="bk_pop" href="#chac.REF.mohiddin.2004">Mohiddin &#x00026; Fananapazir 2004</a>].</p><p><b>Phenotypic variability,</b> even within a family, is considerable. For example, a woman in her thirties who had initially shown orofacial dyskinesia and instability of stance and gait became mute and wheelchair dependent, while her brother, also in his thirties, had seizures and showed only a minor movement disorder [<a class="bk_pop" href="#chac.REF.aasly.1999.322">Aasly et al 1999</a>]. Similarly, different phenotypes have been described in twins [<a class="bk_pop" href="#chac.REF.m_llervahl.2007.1081">M&#x000fc;ller-Vahl et al 2007</a>].</p><p>Molecular genetic testing has identified <i>VPS13A</i> pathogenic variants [<a class="bk_pop" href="#chac.REF.dobsonstone.2002.773">Dobson-Stone et al 2002</a>] in individuals with the characteristic clinical picture but no apparent acanthocytosis [<a class="bk_pop" href="#chac.REF.johnson.1998.556">Johnson et al 1998</a>].</p><p><b>Other clinical findings</b></p><ul><li class="half_rhythm"><div>Splenomegaly is occasionally noted and may be caused by erythrocyte dysfunction and hemolysis as shown by the reduced levels of hemoglobin and haptoglobin.</div></li><li class="half_rhythm"><div>Hepatomegaly may be present, along with elevated liver enzymes; the clinical significance of this is as yet unclear.</div></li><li class="half_rhythm"><div>Autonomic nervous system dysfunction was described in one individual [<a class="bk_pop" href="#chac.REF.kihara.2002.42">Kihara et al 2002</a>].</div></li><li class="half_rhythm"><div>In a few individuals, sleep disturbance was demonstrated by polysomnography [<a class="bk_pop" href="#chac.REF.dolencgroselj.2004">Dolenc-Groselj et al 2004</a>].</div></li><li class="half_rhythm"><div>Retinal detachment was described in a Japanese family, but may be due to other causes [<a class="bk_pop" href="#chac.REF.ogawa.2013.913">Ogawa et al 2013</a>].</div></li><li class="half_rhythm"><div>It is possible that an individual with ChAc could also suffer from another genetic disorder, particularly if the individual was the product of a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> mating. An individual with ChAc was also diagnosed with multidrug resistance (MDR3) deficiency, caused by pathogenic variants in <i>ABCB4</i>; this individual presented with symptoms mimicking <a href="/books/n/gene/wilson/">Wilson disease</a> [<a class="bk_pop" href="#chac.REF.anheim.2010.294">Anheim et al 2010</a>].</div></li></ul><p><b>Other studies</b></p><ul><li class="half_rhythm"><div><b>MR spectroscopy</b> has revealed abnormal proton spectra from the basal ganglia in two individuals with probable ChAc [<a class="bk_pop" href="#chac.REF.antonio_molina.1998.11">Antonio Molina et al 1998</a>].</div></li><li class="half_rhythm"><div><b>Tracer imaging studies</b> of the type presently available in most major medical centers may support a suspicion of ChAc. Regional cerebral glucose metabolism can be measured using <sup>18</sup>F-fluorodeoxy-glucose positron emission tomography (FDG-PET) and regional cerebral perfusion can be depicted with single photon emission computed tomography (SPECT with, e.g., HMPAO or ECD). They show reduced tracer accumulation in the caudate nucleus and putamen [<a class="bk_pop" href="#chac.REF.milanez.2001.1242">Milanez et al 2001</a>, <a class="bk_pop" href="#chac.REF.m_llervahl.2007.1081">M&#x000fc;ller-Vahl et al 2007</a>] and occasionally in the thalamus and frontal cortex. The metabolic changes may precede gross atrophy or MRI signal change [<a class="bk_pop" href="#chac.REF.ismailogullari.2010.2894">Ismailogullari et al 2010</a>].</div></li><li class="half_rhythm"><div><b>Imaging of dopaminergic and serotoninergic transmission</b> measured by presynaptic D<sub>2</sub>-receptor binding (DAT) in the striatum and serotonin transporters in the hypothalamus midbrain is described to be within normal levels. However, hemispheric asymmetry was found in one individual [<a class="bk_pop" href="#chac.REF.m_llervahl.2007.1081">M&#x000fc;ller-Vahl et al 2007</a>].</div></li><li class="half_rhythm"><div><b>CT scanning of leg muscles</b> reveals a selective pattern of fatty change that (in contrast to <a href="/books/n/gene/mcleod/">McLeod syndrome</a>) tends to be symmetric [<a class="bk_pop" href="#chac.REF.ishikawa.2000.1113">Ishikawa et al 2000</a>].</div></li><li class="half_rhythm"><div><b>CSF studies,</b> when reported, have been normal.</div></li><li class="half_rhythm"><div><b>EEG</b> may show temporal spikes, both interictally and with seizure onset [<a class="bk_pop" href="#chac.REF.tiftikcioglu.2006.46">Tiftikcioglu et al 2006</a>, <a class="bk_pop" href="#chac.REF.scheid.2009.1419">Scheid et al 2009</a>].</div></li><li class="half_rhythm"><div><b>Peripheral nerve biopsy</b> shows loss of myelinated fibers, particularly those of larger diameter. Unmyelinated fibers may also be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Signs of regeneration are observed [<a class="bk_pop" href="#chac.REF.sorrentino.1999.175">Sorrentino et al 1999</a>].</div></li><li class="half_rhythm"><div><b>Muscle biopsy</b> reveals findings indicative of both neurogenic and myopathic atrophy [<a class="bk_pop" href="#chac.REF.liu.2012.s57">Liu et al 2012</a>]. "Nemaline" rods in muscle have been reported, although their exact composition is unknown [<a class="bk_pop" href="#chac.REF.tamura.2005.516">Tamura et al 2005</a>].</div></li></ul><p><b>Neuropathology.</b> On autopsy, the cerebral cortex appears unaffected. There is macroscopic bilateral atrophy of the caudate nucleus, the putamen, and the globus pallidus, corresponding to histologic loss of neurons and gliosis, which is particularly severe in the caudate and less so in the putamen and the external and internal pallidum [<a class="bk_pop" href="#chac.REF.vital.2002.77">Vital et al 2002</a>, <a class="bk_pop" href="#chac.REF.arzberger.2005.1679">Arzberger et al 2005</a>, <a class="bk_pop" href="#chac.REF.bader.2008">Bader et al 2008</a>, <a class="bk_pop" href="#chac.REF.ishida.2009.85">Ishida et al 2009</a>]. Pronounced neuronal loss in the substantia nigra is the likely neuropathologic correlate of parkinsonism. Gliosis and extraneuronal pigment, but no Lewy bodies, are observed in the substantia nigra. The <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> coeruleus, inferior olives, and cerebellum appear unaffected. Loss of spinal cord anterior horn cells, a correlate of neurogenic muscle atrophy, is seen in some of the autopsies of individuals with ChAc. Gliosis may also occur in the thalamus.</p><p>Glutamic acid decarboxylase (GAD) and choline acetyltransferase levels were reported to be normal in caudate nucleus and putamen; GAD was increased in substantia nigra in the absence of neuronal loss. Substance P and dopamine metabolites were reduced in the brains of individuals with ChAc [<a class="bk_pop" href="#chac.REF.de_yebenes.1988.300">de Yebenes et al 1988</a>, <a class="bk_pop" href="#chac.REF.galatioto.1993.49">Galatioto et al 1993</a>].</p></div><div id="chac.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Presently available data are inconclusive with regard to <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation in ChAc.</p></div><div id="chac.Nomenclature"><h3>Nomenclature</h3><p>In the recent literature, the term "chorea-acanthocytosis" is more frequently used than the term "choreoacanthocytosis."</p><p>The term "neuroacanthocytosis" is nonspecific and may refer to any disorder with neurologic abnormalities and acanthocytosis, including <a href="/books/n/gene/mcleod/">McLeod syndrome</a>, <a href="/books/n/gene/ab-lipo-p/">abetalipoproteinemia</a> (Bassen-Kornzweig syndrome), or hypobetalipoproteinemia.</p><p>The term "Levine-Critchley syndrome" is inconclusive. The kindred initially reported by <a class="bk_pop" href="#chac.REF.critchley.1967.132">Critchley et al [1967]</a> has been confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to harbor a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>VPS13A</i> [<a class="bk_pop" href="#chac.REF.velayosbaeza.2011.1330">Velayos-Baeza et al 2011</a>]. The family reported by <a class="bk_pop" href="#chac.REF.levine.1968.403">Levine et al [1968]</a> in particular had atypical features, and proper evaluation with molecular techniques has not been made.</p><p>Other outdated terms include "chorea-amyotrophy-acanthocytosis syndrome" and "<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> amyotrophic chorea with acanthocytosis."</p></div><div id="chac.Prevalence"><h3>Prevalence</h3><p>The number of individuals with ChAc known worldwide is estimated at 500-1,000. Reports have come from practically all ethnic backgrounds.</p></div></div><div id="chac.Genetically_Related_Allelic_Disorde"><h2 id="_chac_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>VPS13A</i>.</p></div><div id="chac.Differential_Diagnosis"><h2 id="_chac_Differential_Diagnosis_">Differential Diagnosis</h2><p>Because of the protean manifestations of chorea-acanthocytosis (ChAc), a wide range of disorders needs to be considered in the differential diagnosis, including the general categories of parkinsonian syndromes (see <a href="/books/n/gene/parkinson-overview/">Parkinson Disease Overview</a>). choreiform and other movement disorders, epilepsy disorders, and neuromuscular disorders [<a class="bk_pop" href="#chac.REF.danek.2005.171">Danek et al 2005</a>].</p><p><a href="/books/n/gene/huntington/"><b>Huntington disease</b></a>
<b>(HD)</b> is a progressive disorder of motor, cognitive, and psychiatric disturbances. In addition to the almost identical choreiform movement disorder and imaging findings of HD and ChAc, the changes in personality and behavior are similar [<a class="bk_pop" href="#chac.REF.kutcher.1999.187">Kutcher et al 1999</a>]. Seizures are much more common in ChAc than in HD, where they are only reported in the juvenile form. Increased serum concentrations of CK or liver enzymes are usually not seen in HD. The mean age of onset of HD is 35 to 44 years; the median survival is 15 to 18 years after onset. Neuropathology in HD is more widespread and (in contrast to ChAc) also involves the cerebral cortex [<a class="bk_pop" href="#chac.REF.vonsattel.1998.369">Vonsattel &#x00026; DiFiglia 1998</a>]. The diagnosis of HD rests on the detection of an expansion of a CAG/polyglutamine tract in <i>HTT</i> (<i>IT15</i>). HD is characterized by <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance and <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a>, i.e., earlier disease onset in subsequent generations.</p><p><a href="/books/n/gene/wilson/"><b>Wilson disease</b></a><b>.</b> Individuals who present with neuropsychiatric disease and elevated liver enzymes should be evaluated for Wilson disease, in addition to neuroacanthocytosis syndromes. Wilson disease is a disorder of copper metabolism with onset ranging from age three years to more than 50 years. The liver disease includes recurrent jaundice, simple acute self-limited hepatitis-like illness, autoimmune-type hepatitis, fulminant hepatic failure, or chronic liver disease. Neurologic presentations include movement disorders (tremor, poor coordination, loss of fine-motor control, chorea, choreoathetosis) or rigid dystonia (mask-like facies, rigidity, gait disturbance, pseudobulbar involvement). Psychiatric disturbance includes depression, neurotic behaviors, disorganization of personality and, occasionally, intellectual deterioration. Treatment by copper chelating agents or zinc can prevent the development of hepatic, neurologic, and psychiatric findings in asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and can reduce findings in many symptomatic individuals.</p><p>Diagnosis depends on the detection of low serum copper and ceruloplasmin concentrations and increased urinary copper excretion. Pathogenic variants in <i>ATP7B</i> are causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> [<a class="bk_pop" href="#chac.REF.gow.2000.415">Gow et al 2000</a>].</p><p><a href="/books/n/gene/mcleod/"><b>McLeod neuroacanthocytosis syndrome</b></a>
<b>(MLS)</b> is a multisystem disorder with central nervous system (CNS), neuromuscular, and hematologic manifestations in males that overlap considerably with those seen in ChAc [<a class="bk_pop" href="#chac.REF.danek.2001.755">Danek et al 2001</a>]. CNS manifestations are typical of neurodegenerative basal ganglia disease including movement disorder, cognitive impairment, and psychiatric symptoms. Neuromuscular manifestations include a mostly subclinical sensorimotor axonopathy, muscle weakness, or atrophy. The hematologic manifestations are red blood cell acanthocytosis, compensated hemolysis, and the McLeod blood group <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> resulting from absent expression of the Kx erythrocyte antigen and reduced expression of the Kell blood group antigens. This latter finding distinguishes MLS from ChAc, in which Kell blood group antigen expression is normal. Heterozygous females have <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for the Kell blood group antigens and RBC acanthocytosis but only rarely have CNS and neuromuscular manifestations. Pathogenic variants in <i>XK</i> are causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>.</p><p><a href="/books/n/gene/pkan/"><b>Pantothenate kinase-associated neurodegeneration</b></a>
<b>(PKAN)</b> is characterized by progressive dystonia and basal ganglia iron deposition with onset usually before age ten years. Commonly associated features include dysarthria, rigidity, and pigmentary retinopathy. About 25% of individuals have an "atypical" presentation with onset after age ten years, prominent speech defects, psychiatric disturbances, and more gradual progression of disease. Acanthocytes are often seen in PKAN [<a class="bk_pop" href="#chac.REF.hayflick.2003.33">Hayflick et al 2003</a>, <a class="bk_pop" href="#chac.REF.pellecchia.2005.1810">Pellecchia et al 2005</a>]. "<b>HARP syndrome</b>" (<i>h</i>ypoprebetalipoproteinemia, <i>a</i>canthocytosis, <a href="/books/n/gene/rp-overview/"><i>r</i>etinitis pigmentosa</a>, and <i>p</i>allidal degeneration) is allelic with PKAN [<a class="bk_pop" href="#chac.REF.ching.2002.1673">Ching et al 2002</a>, <a class="bk_pop" href="#chac.REF.houlden.2003.1423">Houlden et al 2003</a>].</p><p>The "eye of the tiger" is a characteristic MRI finding identified on transverse images of the globus pallidus as a central region of hyperintensity surrounded by a rim of hypointensity. In greater than 98% of individuals with neurodegeneration with brain iron accumulation and the "eye of the tiger" sign on MRI at least one <i>PANK2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p>See also <a href="/books/n/gene/nbia-ov/">Neurodegeneration with Brain Iron Accumulation Disorders Overview</a>.</p><p><a href="/books/n/gene/hd-l2/"><b>Huntington disease-like 2</b></a>
<b>(HDL2)</b> typically presents in midlife with a picture similar to ChAc and HD, with a relentlessly progressive triad of movement, emotional, and cognitive abnormalities progressing to death over ten to 20 years [<a class="bk_pop" href="#chac.REF.margolis.2004.670">Margolis et al 2004</a>]. <i>JPH3</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with HDL2 [<a class="bk_pop" href="#chac.REF.holmes.2001.377">Holmes et al 2001</a>]. In the presence of a clinical syndrome consistent with HDL2, 41 or more CTG trinucleotide repeats in <i>JPH3</i> is considered diagnostic of HDL2. HDL2 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner; to date, it has only been reported in individuals of African ancestry. Acanthocytosis is found in a few individuals with HDL2 [<a class="bk_pop" href="#chac.REF.walker.2003.1002">Walker et al 2003</a>].</p><p><a href="/books/n/gene/ab-lipo-p/"><b>Abetalipoproteinemia</b></a>
<b>(ABL) and hypobetalipoproteinemia (HBL)</b> share acanthocytosis with ChAc and MLS, as well as the presence of dysarthria, neuropathy, and areflexia, but differ in their hallmark findings of pigmentary retinopathy, vitamin E deficiency, steatorrhea, and absence of basal ganglia movement disorder. ABL and HBL are caused by pathogenic variants in the genes encoding the microsomal triglyceride transfer protein and apolipoprotein B, respectively. ABL is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. HBL has clinical manifestations in both the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> and <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> states. Neurologic findings include the following:</p><ul><li class="half_rhythm"><div>A progressive spinocerebellar degeneration</div></li><li class="half_rhythm"><div>A demyelinating sensorimotor and axonal peripheral neuropathy with hyporeflexia, diminished vibration and position sense, ataxia of gait, dysmetria, and dysarthria</div></li><li class="half_rhythm"><div>Rarely, pyramidal tract signs</div></li><li class="half_rhythm"><div>Rarely, cranial nerve involvement</div></li></ul><p><b>Tourette syndrome</b> is often diagnosed during initial stages of ChAc [<a class="bk_pop" href="#chac.REF.saiki.2004.833">Saiki et al 2004</a>]. Its picture of motor and vocal tics, obsessive-compulsive behavior, and impaired impulse control can be similar to part of the ChAc spectrum.</p><p><a href="/books/n/gene/lns/"><b>Lesch-Nyhan syndrome</b></a><b>,</b> an <a class="def" href="/books/n/gene/glossary/def-item/x-linked-recessive/">X-linked recessive</a> disorder caused by decreased activity of the enzyme hypoxanthine guanine phosphoribosyl transferase (HPRT), is characterized by neurologic dysfunction, cognitive and behavioral disturbances, and uric acid overproduction (hyperuricemia). The most common presenting features are hypotonia and developmental delay, which are evident by age three to six months. Affected individuals are delayed in sitting; most never walk. Within the first few years, extrapyramidal involvement (e.g., dystonia, choreoathetosis, opisthotonus) and pyramidal involvement (e.g., spasticity, hyperreflexia, and extensor plantar reflexes) become evident. Persistent self-injurious behavior (biting the fingers, hands, lips, and cheeks; banging the head or limbs) is a hallmark of the disease.</p><p>HPRT enzyme activity that is less than 1.5% normal in cells from any tissue (e.g., blood, cultured fibroblasts, or lymphoblasts) establishes the diagnosis of Lesch-Nyhan syndrome.</p><p><b>Other disorders.</b> Several other rare genetic movement disorders may be confused with ChAc. These include <a href="/books/n/gene/drpla/">dentatorubral-pallidoluysian atrophy</a> (DRPLA), benign hereditary chorea, <a href="/books/n/gene/inad/">infantile neuroaxonal dystrophy</a> and other disorders that may mimic HD [<a class="bk_pop" href="#chac.REF.ross.1997.305">Ross et al 1997</a>, <a class="bk_pop" href="#chac.REF.xiang.1998.1431">Xiang et al 1998</a>, <a class="bk_pop" href="#chac.REF.kambouris.2000.445">Kambouris et al 2000</a>, <a class="bk_pop" href="#chac.REF.curtis.2001.350">Curtis et al 2001</a>, <a class="bk_pop" href="#chac.REF.fernandez.2001.106">Fernandez et al 2001</a>, <a class="bk_pop" href="#chac.REF.richfield.2002.327">Richfield et al 2002</a>, <a class="bk_pop" href="#chac.REF.xu.2004.299">Xu et al 2004</a>, <a class="bk_pop" href="#chac.REF.paisanruiz.2009.19">Paisan-Ruiz et al 2009</a>].</p></div><div id="chac.Management"><h2 id="_chac_Management_">Management</h2><div id="chac.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with chorea-acanthocytosis (ChAc), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Swallowing assessment</div></li><li class="half_rhythm"><div>Electroencephalography to allow for early detection of signs indicating an increased risk for epileptic seizures and consideration of use of antiepileptic drugs</div></li><li class="half_rhythm"><div>Neuropsychological assessment to identify and address possible psychosocial complications</div></li><li class="half_rhythm"><div>Electromyography and nerve conduction testing to document the extent of neuromuscular disease</div></li><li class="half_rhythm"><div>Physical therapy evaluation to identify and address areas of possible benefit</div></li></ul><p>Clinical genetics consultation may be considered.</p></div><div id="chac.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Botulinum toxin may be helpful in increasing the oro-facio-lingual dystonia that interferes with eating [<a class="bk_pop" href="#chac.REF.schneider.2006.940">Schneider et al 2006</a>].</p><p>Assistance with feeding is often necessary to prevent aspiration [<a class="bk_pop" href="#chac.REF.aasly.1999.322">Aasly et al 1999</a>].</p><p>With progression to mutism, evaluation for computer-assisted speech systems is appropriate [<a class="bk_pop" href="#chac.REF.aasly.1999.322">Aasly et al 1999</a>].</p><p>Mechanical protective devices may be needed for complications such as teeth grinding, head banging, and repeated falls. Use of a mouth guard has been reported to reduce psychiatric symptoms [<a class="bk_pop" href="#chac.REF.fontenelle.2008.1186">Fontenelle &#x00026; Leite 2008</a>].</p><p>Splints can be tried for foot drop. Since the equinovarus deformity has a dystonic component, local injections of botulinum toxin have been used.</p><p>Phenytoin, clobazam, valproate, and levetiracetam are reported to be effective for seizure control.</p><p>Use of psychiatric medications such as antidepressant or antipsychotic medications is based on conventional approaches. Behavioral compulsions, particularly those resulting in self-harm, should be aggressively treated with antidepressant medications that target obsessive-compulsive symptoms.</p><p>Use of dopamine antagonists/depleters such as atypical neuroleptics or tetrabenazine as for chorea or Tourette syndrome should also be offered, although <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should be carefully monitored for side effects of parkinsonism and depression [<a class="bk_pop" href="#chac.REF.borchardt.2000.1055">Borchardt et al 2000</a>].</p><p>Deep brain stimulation of the globus pallidus pars interna may improve chorea and dystonia [<a class="bk_pop" href="#chac.REF.miquel.2013.e79241">Miquel et al 2013</a>].</p></div><div id="chac.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>The following are advised:</p><ul><li class="half_rhythm"><div>Prevention of falls</div></li><li class="half_rhythm"><div>Keeping an object such as a handkerchief in the mouth to diminish damage to lips and tongue from involuntary biting</div></li></ul></div><div id="chac.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Monitoring of nutritional status and adaptation of diet to assure adequate caloric intake and to prevent aspiration</div></li><li class="half_rhythm"><div>EEG approximately every third year</div></li></ul></div><div id="chac.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Seizure-provoking circumstances (e.g., sleep deprivation, alcohol intake)</div></li><li class="half_rhythm"><div>Anticonvulsants that may worsen involuntary movements (e.g., carbamazepine, lamotrigine)</div></li></ul></div><div id="chac.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#chac.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="chac.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Deep brain stimulation was initially investigated in a few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with variable success [<a class="bk_pop" href="#chac.REF.wihl.2001.572">Wihl et al 2001</a>, <a class="bk_pop" href="#chac.REF.burbaud.2002.204">Burbaud et al 2002</a>, <a class="bk_pop" href="#chac.REF.ruiz.2009.1546">Ruiz et al 2009</a>]. A recent multicenter retrospective study by <a class="bk_pop" href="#chac.REF.miquel.2013.e79241">Miquel et al [2013]</a> indicates that this therapy may be effective for several symptoms.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="chac.Other"><h3>Other</h3><p>The atypical dopamine antagonist clozapine was at least temporarily effective in a single observation [<a class="bk_pop" href="#chac.REF.wihl.2001.572">Wihl et al 2001</a>].</p><p>The antiepileptic drug levetiracetam was effective in eliminating trunk jerks, blinking, and head nodding in a single case [<a class="bk_pop" href="#chac.REF.lin.2006.38">Lin et al 2006</a>].</p><p>Dopamine decreased dystonia in one individual but was ineffective in his sister [Kobal, personal communication].</p></div></div><div id="chac.Genetic_Counseling"><h2 id="_chac_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="chac.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Chorea-acanthocytosis (ChAc) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="chac.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The unaffected parents are obligate carriers (heterozygotes) and have an alteration in one copy of <i>VPS13A</i>.</div></li><li class="half_rhythm"><div>Consanguinity of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals' parents has been noted in a number of reports [<a class="bk_pop" href="#chac.REF.sorrentino.1999.175">Sorrentino et al 1999</a>, <a class="bk_pop" href="#chac.REF.dobsonstone.2002.773">Dobson-Stone et al 2002</a>, <a class="bk_pop" href="#chac.REF.bohlega.2003.403">Bohlega et al 2003</a>, <a class="bk_pop" href="#chac.REF.alasmi.2005.1256">Al-Asmi et al 2005</a>, <a class="bk_pop" href="#chac.REF.sokolov.2012.40">Sokolov et al 2012</a>].</div></li><li class="half_rhythm"><div>Current knowledge indicates that carriers are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with ChAc are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>VPS13A</i>.</div></li><li class="half_rhythm"><div>The risk that the offspring of an individual with ChAc will develop ChAc depends on the other parent's <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status and/or the occurrence of <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> mutation in the other parent&#x02019;s <i>VPS13A</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="chac.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives usually requires prior identification of the pathogenic variants in the family. In those instances in which the diagnosis of ChAc has been confirmed by western blot analysis, but the specific pathogenic variants are unknown, haplotyping (i.e., linkage analysis) could be used.</p></div><div id="chac.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Possible <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> ChAc.</b> Some families with a clinical syndrome compatible with ChAc and apparent autosomal dominant transmission have been reported. It is not known if these disorders are linked to the <i>VPS13A</i> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> [<a class="bk_pop" href="#chac.REF.levine.1968.403">Levine et al 1968</a>, <a class="bk_pop" href="#chac.REF.marson.2003.188">Marson et al 2003</a>].</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#chac.REF.saiki.2003.1614">Saiki et al [2003]</a> reported <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> ChAc in a family with an inheritance pattern suggesting autosomal dominant transmission and where only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified (several reports have been published on this family [<a class="bk_pop" href="#chac.REF.saiki.2004.833">Saiki et al 2004</a>, <a class="bk_pop" href="#chac.REF.ishida.2009.85">Ishida et al 2009</a>]). Similarly, another unrelated patient was studied as a putative autosomal dominant case [<a class="bk_pop" href="#chac.REF.saiki.2007.848">Saiki et al 2007</a>]. <a class="bk_pop" href="#chac.REF.bader.2009.95">Bader et al [2009]</a> expressed doubts about the proposed <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> in these cases; new <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the original <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> identified a second pathogenic variant [<a class="bk_pop" href="#chac.REF.tomiyasu.2011.620">Tomiyasu et al 2011</a>], confirming that inheritance in this family was <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> [<a class="bk_pop" href="#chac.REF.danek.2012.905">Danek et al 2012</a>, <a class="bk_pop" href="#chac.REF.walker.2012b.198">Walker et al 2012b</a>].</div></li><li class="half_rhythm"><div>Pseudodominant inheritance of ChAc was observed in a family in which the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother was <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a <i>VPS13A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#chac.REF.bohlega.2003.403">Bohlega et al 2003</a>] (family 1).</div></li></ul><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="chac.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>VPS13A</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for CHAC are possible.</p></div></div><div id="chac.Resources"><h2 id="_chac_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Advocacy for Neuroacanthocytosis Patients</b></div><div>39 Coleherne Court</div><div>London SW5 0DN</div><div>United Kingdom</div><div><b>Phone:</b> 44 (0) 20 7460-8874</div><div><b>Email:</b> ginger@naadvocacy.org; Jen@naadvocacy.org</div><div><a href="http://www.naadvocacy.org/welcome-advocacy-neuroacanthocytosis" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.naadvocacy.org</a></div></li><li class="half_rhythm"><div><b>Huntington's Disease Society of America (HDSA)</b></div><div><a href="http://www.hdsa.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hdsa.org</a></div></li><li class="half_rhythm"><div><b>Neuroacanthocytosis Database (Registry)</b></div><div>Prof. Adrian Danek</div><div>Neurologische Klinik</div><div>POB 701260</div><div>Germany</div><div><b>Phone:</b> 49 (89) 4400-76676</div><div><b>Email:</b> adrian.danek@med.uni-muenchen.de</div><div><a href="https://www.euro-hd.net/html/na/registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euro-hd.net/html/na/registry</a></div></li></ul></div><div id="chac.Molecular_Genetics"><h2 id="_chac_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="chac.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Chorea-Acanthocytosis: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1387/table/chac.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chac.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_chac.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_chac.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_chac.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_chac.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_chac.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_chac.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_chac.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/23230" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>VPS13A</i></a></td><td headers="hd_b_chac.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=23230" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_chac.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96RL7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Vacuolar protein sorting-associated protein 13A</a></td><td headers="hd_b_chac.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/VPS13A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VPS13A database</a></td><td headers="hd_b_chac.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=VPS13A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VPS13A</a></td><td headers="hd_b_chac.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=VPS13A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VPS13A</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="chac.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="chac.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Chorea-Acanthocytosis (<a href="/omim/200150,605978" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1387/table/chac.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__chac.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/200150" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">200150</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHOREOACANTHOCYTOSIS; CHAC</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605978" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605978</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, A; VPS13A</td></tr></tbody></table></div></div><div id="chac.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The original <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> symbol designation, <i>CHAC</i>, was changed to <i>VPS13A</i> to acknowledge its similarity with <i>VPS13/SOI1</i> in yeast. Three other human genes belong to the same family: <i>VPS13B</i>, <i>VPS13C</i>, and <i>VPS13D</i>, on chromosomes 8q22, 15q21, and 1p36 respectively [<a class="bk_pop" href="#chac.REF.velayosbaeza.2004.536">Velayos-Baeza et al 2004</a>]. <i>VPS13B</i> (<i>COH1</i>) is altered in individuals with <a href="/books/n/gene/cohen/">Cohen syndrome</a>, a rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder characterized by non-progressive psychomotor retardation and microcephaly, retinal dystrophy, and characteristic facial features [<a class="bk_pop" href="#chac.REF.kolehmainen.2003.1359">Kolehmainen et al 2003</a>]. <i>VPS13C</i> is altered in early-onset Parkinson disease [<a class="bk_pop" href="#chac.REF.lesage.2016.500">Lesage et al 2016</a>]; <i>VPS13C</i> variants have also been associated with susceptibility for type 2 diabetes [<a class="bk_pop" href="#chac.REF.saxena.2010.142">Saxena et al 2010</a>, <a class="bk_pop" href="#chac.REF.strawbridge.2011.2624">Strawbridge et al 2011</a>]. <i>VPS13D</i> is altered in <a href="/books/n/gene/vps13d-md/"><i>VPS13D</i> movement disorder</a> [<a class="bk_pop" href="#chac.REF.gauthier.2018.1089">Gauthier et al 2018</a>, <a class="bk_pop" href="#chac.REF.seong.2018.1075">Seong et al 2018</a>]. All four human <i>VPS13</i> genes have multiple <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants.</p><p>Little is known about the function of chorein. Amino acid <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> failed to identify conserved domains, motifs, or identifiable structural features [<a class="bk_pop" href="#chac.REF.rampoldi.2001.119">Rampoldi et al 2001</a>]. Vps13p, chorein's yeast homologue, is required for proper intracellular trafficking of certain trans-Golgi network (TGN) proteins [<a class="bk_pop" href="#chac.REF.brickner.1997.23">Brickner &#x00026; Fuller 1997</a>], and for multiple aspects of prospore membrane morphogenesis [<a class="bk_pop" href="#chac.REF.park.2012.3004">Park &#x00026; Neiman 2012</a>]. It is reasonable to hypothesize a role for chorein similar to that of its yeast counterpart. Indeed, chorein may control one or more steps in the cycling of proteins through the TGN to early and late endosomes, lysosomes, and the plasma membrane.</p><p>The homologous protein in the ciliate <i>Tetrahymena thermophila</i>, TtVPS13A, was detected in a mass spectrometry analysis of the phagosome proteome [<a class="bk_pop" href="#chac.REF.jacobs.2006.1990">Jacobs et al 2006</a>] and then shown to localize in the phagosome membrane and to be necessary for efficient phagocytosis [<a class="bk_pop" href="#chac.REF.samaranayake.2011.1207">Samaranayake et al 2011</a>]. Therefore, it is possible that chorein and/or other members of the human protein family are involved in autophagy.</p><p>Chorein has been reported to localize in the termini of extended neurites in rat PC12 cells and it has been proposed that it may be involved in dopamine release and exocytosis of dense-core vesicles [<a class="bk_pop" href="#chac.REF.hayashi.2012.511">Hayashi et al 2012</a>]. More functional experiments are required to assess chorein's biologic function in mammalian systems.</p><p>A mouse model of chorea-acanthocytosis (ChAc) has been developed. Mice with a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>VPS13A</i> exons 60 and 61 show acanthocytosis and late-onset motor disturbance (gait disturbance and early fall from the rotarod, but no involuntary movements). This contrasts with humans, who typically present with chorea as the major motor symptom. Brain pathology indicated apoptotic cells in the striatum. Levels of homovanillic acid, a dopamine metabolite, were reduced in the midbrain [<a class="bk_pop" href="#chac.REF.tomemori.2005.759">Tomemori et al 2005</a>]. These mice have also been described to have levels of gephyrin (a GABA<sub>A</sub> receptor-anchoring protein) and GABRG2 (GABA<sub>A</sub> receptor &#x003b3;2 subunit) immunoreactivity in the striatum and hippocampus that are significantly higher than those in wild type mice, suggesting that loss of chorein may lead to a compensatory upregulation of these proteins to prevent striatal degeneration [<a class="bk_pop" href="#chac.REF.kurano.2006.438">Kurano et al 2006</a>].</p><p><b>Gene structure.</b>
<i>VPS13A</i> is organized in 74 exons over a chromosomal region of about 240 kb. Several transcript variants are known, transcript variant A (<a href="/nuccore/NM_033305.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_033305.2</a>) (exons 1-68, 70-73) being the main expressed form. Alteration/absence of transcript A-encoded chorein is sufficient to cause ChAc [<a class="bk_pop" href="#chac.REF.dobsonstone.2002.773">Dobson-Stone et al 2002</a>]. At least two other 3'-end alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> forms are expressed: transcript variant B (exons 1-68, 69) and transcript variant D (1-68, 68b); the approximate sizes of these three <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> forms are 11.2, 10, and 9.6kb for transcript variants A, B, and D, respectively. Other splicing variants, probably minor forms, have also been detected [<a class="bk_pop" href="#chac.REF.velayosbaeza.2004.536">Velayos-Baeza et al 2004</a>]. See <a href="/books/NBK1387/#chac.molgen.TA">Table A</a>, <b>Gene</b> for detailed information on transcript variants.</p><p><b>Pathogenic variants.</b> Pathogenic variants are dispersed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and comprise <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>, and <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> mutations [<a class="bk_pop" href="#chac.REF.rampoldi.2001.119">Rampoldi et al 2001</a>, <a class="bk_pop" href="#chac.REF.ueno.2001.121">Ueno et al 2001</a>, <a class="bk_pop" href="#chac.REF.dobsonstone.2002.773">Dobson-Stone et al 2002</a>, <a class="bk_pop" href="#chac.REF.dobsonstone.2004.299">Dobson-Stone et al 2004</a>, <a class="bk_pop" href="#chac.REF.dobsonstone.2005.151">Dobson-Stone et al 2005</a>, <a class="bk_pop" href="#chac.REF.walker.2006.2268">Walker et al 2006</a>, <a class="bk_pop" href="#chac.REF.kageyama.2007.1669">Kageyama et al 2007</a>, <a class="bk_pop" href="#chac.REF.miki.2010.271">Miki et al 2010</a>, <a class="bk_pop" href="#chac.REF.tomiyasu.2011.620">Tomiyasu et al 2011</a>, <a class="bk_pop" href="#chac.REF.velayosbaeza.2011.1330">Velayos-Baeza et al 2011</a>, <a class="bk_pop" href="#chac.REF.walker.2012a.539">Walker et al 2012a</a>, <a class="bk_pop" href="#chac.REF.neutel.2012.293">Neutel et al 2012</a>, <a class="bk_pop" href="#chac.REF.shin.2012.273">Shin et al 2012</a>, <a class="bk_pop" href="#chac.REF.ogawa.2013.913">Ogawa et al 2013</a>, <a class="bk_pop" href="#chac.REF.chen.2013.2442.e11">Chen et al 2013</a>]. A list of many of these pathogenic variants can be found in <a class="bk_pop" href="#chac.REF.velayosbaeza.2008">Velayos-Baeza et al [2008]</a>. Most of the recent pathogenic variants are described in <a class="bk_pop" href="#chac.REF.tomiyasu.2011.620">Tomiyasu et al [2011]</a>.</p><p>Most of the reported large deletions have been described in homozygosis, often constituting founder mutations [<a class="bk_pop" href="#chac.REF.ueno.2001.121">Ueno et al 2001</a>, <a class="bk_pop" href="#chac.REF.dobsonstone.2005.151">Dobson-Stone et al 2005</a>]. Individuals with suspected ancestry from regions with these founder mutations or where other large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/duplications have been described can undergo targeted analysis to detect such pathogenic variants in heterozygosis.</p><p>Noting the high incidence of psychiatric disorders (e.g., mood disorder, schizophrenia) among patients with neuroacanthocytosis, <a class="bk_pop" href="#chac.REF.shimo.2011.196">Shimo et al [2011]</a> sequenced <i>VPS13A</i> in patients with mood disorder; they found three nonsynonymous, two synonymous, and six <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> variants that were absent from controls. These authors propose that these variants may be associated with susceptibility to mood disorder.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Transcript variant A encodes a 3,174-amino-acid protein (<a href="/protein/NP_150648.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_150648.2</a>). Variants B and D encode 3,095- and 3,069-amino-acid proteins, respectively. See <a href="/gene/23230?ordinalpos=1&#x00026;itool=EntrezSystem2.PEntrez.Gene.Gene_ResultsPanel.Gene_RVDocSum" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Entrez Gene</a>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most pathogenic variants in <i>VPS13A</i> are predicted to lead to absence of chorein. The basic defect of the acanthocytic membrane has not yet been determined [<a class="bk_pop" href="#chac.REF.terada.1999.25">Terada et al 1999</a>].</p><p><a class="bk_pop" href="#chac.REF.melone.2002.841">Melone et al [2002]</a> found increased levels of tissue transglutaminase, a cross-linking enzyme involved in assembly of macromolecular structures in two individuals with clinically diagnosed ChAc. The authors suggested that increased cross-linking activity could cause cellular membrane distortions. Such distortions in muscle cells and erythrocytes could lead, respectively, to the increase in serum creatine kinase and the acanthocytosis observed in ChAc.</p><p>Erythrocyte membrane changes in ChAc have been proposed to result from altered Lyn kinase activity [<a class="bk_pop" href="#chac.REF.de_franceschi.2011.5652">De Franceschi et al 2011</a>]. The authors detected increased tyrosine phosphorylation of the cytoskeletal components &#x003b2;-spectrin and adducin and the integral membrane protein band 3 in RBCs from individuals with ChAc, which would alter the composition of the junctional complexes involved in anchoring the membrane to the cytoskeleton. Using a computational approach, several other kinases have been postulated as being involved in generation of acanthocytes in ChAc and MLS [<a class="bk_pop" href="#chac.REF.de_franceschi.2012.e31015">De Franceschi et al 2012</a>]. Protein levels of &#x003b2;-adducin isoform 1 were markedly decreased in erythrocyte membranes from a ChAc patient [<a class="bk_pop" href="#chac.REF.shiokawa.2013.96">Shiokawa et al 2013</a>].</p><p><a class="bk_pop" href="#chac.REF.f_ller.2012.1526">F&#x000f6;ller et al [2012]</a> found an altered signaling of PI3K, Rac1, and PAK1, and a higher fraction of depolymerized actin in ChAc erythrocytes, indicating an impaired assembly of the junctional complex. An effect of reduced chorein levels in actin depolymerization has also been reported in vascular endothelial cells [<a class="bk_pop" href="#chac.REF.alesutan.2013.728">Alesutan et al 2013</a>]. <a class="bk_pop" href="#chac.REF.shiokawa.2013.96">Shiokawa et al [2013]</a> reported a reduction of b-actin levels in ChAc RBCs.</p><p><a class="bk_pop" href="#chac.REF.siegl.2013.e76715">Siegl et al [2013]</a> reported reduced physiologic responses (drug-induced endovesiculation and lysophosphatidic acid-induced phosphatidylserine exposure and calcium uptake) of RBCs from individuals with neuroacanthocytosis (ChAc, MLS, PKAN), and suggested an "acanthocytic state" of the red cell where alterations in functional and interdependent membrane properties arise together with an acanthocytic cell shape.</p><p>Regulation of secretion and aggregation of blood platelets has recently been proposed [<a class="bk_pop" href="#chac.REF.schmidt.2013.2799">Schmidt et al 2013</a>]. The authors detected altered cytoskeletal structures in platelets from patients with ChAc, as well as reduced levels of PI3K and PAK1, involved in regulation of the actin network, and of VAMP8, required for granule secretion.</p></div></div><div id="chac.References"><h2 id="_chac_References_">References</h2><div id="chac.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="chac.REF.aasly.1999.322">Aasly J, Skandsen T, Ro M. Neuroacanthocytosis--the variability of presenting symptoms in two siblings. <span><span class="ref-journal">Acta Neurol Scand. </span>1999;<span class="ref-vol">100</span>:322–5.</span> [<a href="/pubmed/10536920" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10536920</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.alasmi.2005.1256">Al-Asmi A, Jansen AC, Badhwar A, Dubeau F, Tampieri D, Shustik C, Mercho S, Savard G, Dobson-Stone C, Monaco AP, Andermann F, Andermann E. Familial temporal lobe epilepsy as a presenting feature of choreoacanthocytosis. <span><span class="ref-journal">Epilepsia. </span>2005;<span class="ref-vol">46</span>:1256–63.</span> [<a href="/pubmed/16060937" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16060937</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.alesutan.2013.728">Alesutan I, Seifert J, Pakladok T, Rheinlaender J, Lebedeva A, Towhid ST, Stournaras C, Voelkl J, Schaffer TE, Lang F. Chorein sensitivity of actin polymerization, cell shape and mechanical stiffness of vascular endothelial cells. <span><span class="ref-journal">Cell Physiol Biochem. </span>2013;<span class="ref-vol">32</span>:728–42.</span> [<a href="/pubmed/24080826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24080826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.anheim.2010.294">Anheim M, Chamouard P, Rudolf G, Ellero B, Vercueil L, Goichot B, Marescaux C, Tranchant C. Unexpected combination of inherited chorea-acanthocytosis with MDR3 (ABCB4) defect mimicking Wilson's disease. <span><span class="ref-journal">Clinical genetics. </span>2010;<span class="ref-vol">78</span>:294–5.</span> [<a href="/pubmed/20695873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20695873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.antonio_molina.1998.11">Antonio Molina J, Manuel Garc&#x000ed;a-Segura J, Benito-Le&#x000f3;n J, Javier Jim&#x000e9;nez-Jim&#x000e9;nez F, Martin&#x000e9;z V, Via&#x000f1;o J, Bermejoa F. In vivo proton magnetic resonance spectroscopy in patients with neuroacanthocytosis. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>1998;<span class="ref-vol">4</span>:11–5.</span> [<a href="/pubmed/18591083" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18591083</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.arzberger.2005.1679">Arzberger T, Heinsen H, Buresch N, Dobson-Stone C, Danek A, Kretzschmar H. The neuropathology of chorea-acanthocytosis: from stereology to an immunohistochemical detection of chorein. <span><span class="ref-journal">Mov Disord. </span>2005;<span class="ref-vol">20</span>:1679.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.bader.2008">Bader B, Arzberger T, Heinsen H, Dobson-Stone C, Kretzschmar HA, Danek A. Neuropathology of chorea-acanthocytosis. In: Walker RH, Saiki S, Danek A, eds. <em>Neuroacanthocytosis Syndromes II</em>. Berlin, Germany: Springer-Verlag; 2008:187-95.</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.bader.2009.95">Bader B, Velayos-Baeza A, Walker RH, Danek A. Dominant transmission of chorea-acanthocytosis with VPS13A mutations remains speculative. <span><span class="ref-journal">Acta Neuropathol. </span>2009;<span class="ref-vol">117</span>:95–96.</span> [<a href="/pubmed/18661137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18661137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.bader.2011.340">Bader B, Vollmar C, Ackl N, Ebert A, la Foug&#x000e8;re C, Noachtar S, Danek A. Bilateral temporal lobe epilepsy confirmed with intracranial EEG in chorea-acanthocytosis. <span><span class="ref-journal">Seizure. </span>2011;<span class="ref-vol">20</span>:340–2.</span> [<a href="/pubmed/21251854" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21251854</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.bader.2010.127">Bader B, Walker RH, Vogel M, Prosiegel M, McIntosh J, Danek A. Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:127–9.</span> [<a href="/pubmed/19938148" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19938148</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.bayreuther.2010.100">Bayreuther C, Borg M, Ferrero-Vacher C, Chaussenot A, Lebrun C. <span><span class="ref-journal">Rev Neurol (Paris). </span>2010;<span class="ref-vol">166</span>:100–3.</span> [Chorea-acanthocytosis without acanthocytes] [<a href="/pubmed/19497603" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19497603</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.bohlega.2003.403">Bohlega S, Al-Jishi A, Dobson-Stone C, Rampoldi L, Saha P, Murad H, Kareem A, Roberts G, Monaco AP. Chorea-acanthocytosis: clinical and genetic findings in three families from the Arabian peninsula. <span><span class="ref-journal">Mov Disord. </span>2003;<span class="ref-vol">18</span>:403–7.</span> [<a href="/pubmed/12671946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12671946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.borchardt.2000.1055">Borchardt CM, Jensen C, Dean CE, Tori J. Case study: childhood-onset tardive dyskinesia versus choreoacanthocytosis. <span><span class="ref-journal">J Am Acad Child Adolesc Psychiatry. </span>2000;<span class="ref-vol">39</span>:1055–8.</span> [<a href="/pubmed/10939235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10939235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.bostantjopoulou.2000.1271">Bostantjopoulou S, Katsarou Z, Kazis A, Vadikolia C. Neuroacanthocytosis presenting as parkinsonism. <span><span class="ref-journal">Mov Disord. </span>2000;<span class="ref-vol">15</span>:1271–3.</span> [<a href="/pubmed/11104222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11104222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.brickner.1997.23">Brickner JH, Fuller RS. SOI1 encodes a novel, conserved protein that promotes TGN-endosomal cycling of Kex2p and other membrane proteins by modulating the function of two TGN localization signals. <span><span class="ref-journal">J Cell Biol. </span>1997;<span class="ref-vol">139</span>:23–36.</span> [<a href="/pmc/articles/PMC2139830/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2139830</span></a>] [<a href="/pubmed/9314526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9314526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.burbaud.2002.204">Burbaud P, Rougier A, Ferrer X, Guehl D, Cuny E, Arne P, Gross Ch, Bioulac B. Improvement of severe trunk spasms by bilateral high-frequency stimulation of the motor thalamus in a patient with chorea-acanthocytosis. <span><span class="ref-journal">Mov Disord. </span>2002;<span class="ref-vol">17</span>:204–7.</span> [<a href="/pubmed/11835468" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11835468</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.chen.2013.2442.e11">Chen Z, Wang JL, Tang BS, Sun ZF, Shi YT, Shen L, Lei LF, Wei XM, Xiao JJ, Hu ZM, Pan Q, Xia K, Zhang QY, Dai MZ, Liu Y, Ashizawa T, Jiang H. Using next-generation sequencing as a genetic diagnostic tool in rare autosomal recessive neurologic Mendelian disorders. <span><span class="ref-journal">Neurobiol Aging. </span>2013;<span class="ref-vol">34</span>:2442.e11.</span> [<a href="/pubmed/23726790" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23726790</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.ching.2002.1673">Ching KH, Westaway SK, Gitschier J, Higgins JJ, Hayflick SJ. HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">58</span>:1673–4.</span> [<a href="/pubmed/12058097" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12058097</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.critchley.1967.132">Critchley EM, Clark DB, Wikler A. An adult form of acanthocytosis. <span><span class="ref-journal">Trans Am Neurol Assoc. </span>1967;<span class="ref-vol">92</span>:132–7.</span> [<a href="/pubmed/4255726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4255726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.curtis.2001.350">Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:350–4.</span> [<a href="/pubmed/11438811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11438811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.danek.2012.905">Danek A, Bader B, Velayos-Baeza A, Walker RH. Autosomal recessive transmission of chorea-acanthocytosis confirmed. <span><span class="ref-journal">Acta Neuropathol. </span>2012;<span class="ref-vol">123</span>:905–6.</span> [<a href="/pmc/articles/PMC4629413/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4629413</span></a>] [<a href="/pubmed/22476160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22476160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.danek.2005.171">Danek A, Jung HH, Melone MA, Rampoldi L, Broccoli V, Walker RH. Neuroacanthocytosis: new developments in a neglected group of dementing disorders. <span><span class="ref-journal">J Neurol Sci. </span>2005;<span class="ref-vol">229-230</span>:171–86.</span> [<a href="/pubmed/15760637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15760637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.danek.2001.755">Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, Kalckreuth W, Watt JM, Corbett AJ, Hamdalla HH, Marshall AG, Sutton I, Dotti MT, Malandrini A, Walker RH, Daniels G, Monaco AP. McLeod neuroacanthocytosis: genotype and phenotype. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">50</span>:755–64.</span> [<a href="/pubmed/11761473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11761473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.danek.2004">Danek A, Sheesley L, Tierney M, Uttner I, Grafman J. Cognitive and neuropsychiatric findings in McLeod syndrome and in chorea-acanthocytosis. In: Danek A, ed. <em>Neuroacanthocytosis Syndromes</em>. Dordrecht, The Netherlands: Springer; 2004:95-115.</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.de_franceschi.2012.e31015">De Franceschi L, Scardoni G, Tomelleri C, Danek A, Walker RH, Jung HH, Bader B, Mazzucco S, Dotti MT, Siciliano A, Pantaleo A, Laudanna C. Computational identification of phospho-tyrosine sub-networks related to acanthocyte generation in neuroacanthocytosis. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>:e31015.</span> [<a href="/pmc/articles/PMC3280254/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3280254</span></a>] [<a href="/pubmed/22355334" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22355334</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.de_franceschi.2011.5652">De Franceschi L, Tomelleri C, Matte A, Brunati AM, Bovee-Geurts PH, Bertoldi M, Lasonder E, Tibaldi E, Danek A, Walker RH, Jung HH, Bader B, Siciliano A, Ferru E, Mohandas N, Bosman GJ. Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity. <span><span class="ref-journal">Blood. </span>2011;<span class="ref-vol">118</span>:5652–63.</span> [<a href="/pmc/articles/PMC3217364/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3217364</span></a>] [<a href="/pubmed/21951684" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21951684</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.de_yebenes.1988.300">de Yebenes JG, Brin MF, Mena MA, De Felipe C, del Rio RM, Bazan E, Martinez A, Fahn S, Del Rio J, Vazquez A, et al.  Neurochemical findings in neuroacanthocytosis. <span><span class="ref-journal">Mov Disord. </span>1988;<span class="ref-vol">3</span>:300–12.</span> [<a href="/pubmed/2905427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2905427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.dobsonstone.2002.773">Dobson-Stone C, Danek A, Rampoldi L, Hardie RJ, Chalmers RM, Wood NW, Bohlega S, Dotti MT, Federico A, Shizuka M, Tanaka M, Watanabe M, Ikeda Y, Brin M, Goldfarb LG, Karp BI, Mohiddin S, Fananapazir L, Storch A, Fryer AE, Maddison P, Sibon I, Trevisol-Bittencourt PC, Singer C, Caballero IR, Aasly JO, Schmierer K, Dengler R, Hiersemenzel LP, Zeviani M, Meiner V, Lossos A, Johnson S, Mercado FC, Sorrentino G, Dupre N, Rouleau GA, Volkmann J, Arpa J, Lees A, Geraud G, Chouinard S, Nemeth A, Monaco AP. Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. <span><span class="ref-journal">Eur J Hum Genet. </span>2002;<span class="ref-vol">10</span>:773–81.</span> [<a href="/pubmed/12404112" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12404112</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.dobsonstone.2004.299">Dobson-Stone C, Velayos-Baeza A, Filippone LA, Westbury S, Storch A, Erdmann T, Wroe SJ, Leenders KL, Lang AE, Dotti MT, Federico A, Mohiddin SA, Fananapazir L, Daniels G, Danek A, Monaco AP. Chorein detection for the diagnosis of chorea-acanthocytosis. <span><span class="ref-journal">Ann Neurol. </span>2004;<span class="ref-vol">56</span>:299–302.</span> [<a href="/pubmed/15293285" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15293285</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.dobsonstone.2005.151">Dobson-Stone C, Velayos-Baeza A, Jansen A, Andermann F, Dubeau F, Robert F, Summers A, Lang AE, Chouinard S, Danek A, Andermann E, Monaco AP. Identification of a VPS13A founder mutation in French Canadian families with chorea-acanthocytosis. <span><span class="ref-journal">Neurogenetics. </span>2005;<span class="ref-vol">6</span>:151–8.</span> [<a href="/pubmed/15918062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15918062</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.dolencgroselj.2004">Dolenc-Groselj L, Jazbec J, Kobal J. Sleep features in chorea-acanthocytosis. In: Danek A, ed. <em>Neuroacanthocytosis Syndromes</em>. Dordrecht, The Netherlands: Springer; 2004:123-5.</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.fernandez.2001.106">Fernandez M, Raskind W, Matsushita M, Wolff J, Lipe H, Bird T. Hereditary benign chorea: clinical and genetic features of a distinct disease. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">57</span>:106–10.</span> [<a href="/pubmed/11445636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11445636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.f_ller.2012.1526">F&#x000f6;ller M, Hermann A, Gu S, Alesutan I, Qadri SM, Borst O, Schmidt EM, Schiele F, vom Hagen JM, Saft C, Schols L, Lerche H, Stournaras C, Storch A, Lang F. Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis. <span><span class="ref-journal">FASEB J. </span>2012;<span class="ref-vol">26</span>:1526–34.</span> [<a href="/pubmed/22227296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22227296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.fontenelle.2008.1186">Fontenelle LF, Leite MA. Treatment-resistant self-mutilation, tics, and obsessive-compulsive disorder in neuroacanthocytosis: a mouth guard as a therapeutic approach. <span><span class="ref-journal">J Clin Psychiatry. </span>2008;<span class="ref-vol">69</span>:1186–7.</span> [<a href="/pubmed/18687019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18687019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.galatioto.1993.49">Galatioto S, Serra S, Batolo D, Marafioti T. Amyotrophic choreo-acanthocytosis: a neuropathological and immunocytochemical study. <span><span class="ref-journal">Ital J Neurol Sci. </span>1993;<span class="ref-vol">14</span>:49–54.</span> [<a href="/pubmed/8473152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8473152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.gauthier.2018.1089">Gauthier J, Meijer IA, Lessel D, Mencacci NE, Krainc D, Hempel M, Tsiakas K, Prokisch H, Rossignol E, Helm MH, Rodan LH, Karamchandani J, Carecchio M, Lubbe SJ, Telegrafi A, Henderson LB, Lorenzo K, Wallace SE, Glass IA, Hamdan FF, Michaud JL, Rouleau GA, Campeau PM. Recessive mutations in &#x0003e;VPS13D cause childhood onset movement disorders. <span><span class="ref-journal">Ann Neurol. </span>2018;<span class="ref-vol">83</span>:1089–95.</span> [<a href="/pubmed/29518281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29518281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.gow.2000.415">Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson's disease: an experience over three decades. <span><span class="ref-journal">Gut. </span>2000;<span class="ref-vol">46</span>:415–9.</span> [<a href="/pmc/articles/PMC1727845/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1727845</span></a>] [<a href="/pubmed/10673307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10673307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.gradstein.2005.1979">Gradstein L, Danek A, Grafman J, Fitzgibbon EJ. Eye movements in chorea-acanthocytosis. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2005;<span class="ref-vol">46</span>:1979–87.</span> [<a href="/pubmed/15914612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15914612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.hayashi.2012.511">Hayashi T, Kishida M, Nishizawa Y, Iijima M, Koriyama C, Nakamura M, Sano A, Kishida S. Subcellular localization and putative role of VPS13A/chorein in dopaminergic neuronal cells. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2012;<span class="ref-vol">419</span>:511–6.</span> [<a href="/pubmed/22366033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22366033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.hayflick.2003.33">Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, Gitschier J. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:33–40.</span> [<a href="/pubmed/12510040" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12510040</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.holmes.2001.377">Holmes SE, O'Hearn E, Rosenblatt A, Callahan C, Hwang HS, Ingersoll-Ashworth RG, Fleisher A, Stevanin G, Brice A, Potter NT, Ross CA, Margolis RL. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:377–8.</span> [<a href="/pubmed/11694876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11694876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.houlden.2003.1423">Houlden H, Lincoln S, Farrer M, Cleland PG, Hardy J, Orrell RW. Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:1423–6.</span> [<a href="/pubmed/14638969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14638969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.huppertz.2008.1393">Huppertz HJ, Kroll-Seger J, Danek A, Weber B, Dorn T, Kassubek J. Automatic striatal volumetry allows for identification of patients with chorea-acanthocytosis at single subject level. <span><span class="ref-journal">J Neural Transm. </span>2008;<span class="ref-vol">115</span>:1393–400.</span> [<a href="/pubmed/18648728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18648728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.ishida.2009.85">Ishida C, Makifuchi T, Saiki S, Hirose G, Yamada M. A neuropathological study of autosomal-dominant chorea-acanthocytosis with a mutation of VPS13A. <span><span class="ref-journal">Acta Neuropathol. </span>2009;<span class="ref-vol">117</span>:85–94.</span> [<a href="/pubmed/18584183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18584183</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.ishikawa.2000.1113">Ishikawa S, Tachibana N, Tabata KI, Fujimori N, Hayashi RI, Takahashi J, Ikeda SI, Hanyu N. Muscle CT scan findings in McLeod syndrome and chorea-acanthocytosis. <span><span class="ref-journal">Muscle Nerve. </span>2000;<span class="ref-vol">23</span>:1113–6.</span> [<a href="/pubmed/10883007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10883007</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.ismailogullari.2010.2894">Ismailogullari S, Caglayan AO, Bader B, Danek A, Korkmaz S, Sharifov E, Kurnaz F, Aksu M. Magnetic resonance spectroscopy in two siblings with chorea-acanthocytosis. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:2894–7.</span> [<a href="/pubmed/20842686" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20842686</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.jacobs.2006.1990">Jacobs ME, DeSouza LV, Samaranayake H, Pearlman RE, Siu KW, Klobutcher LA. The Tetrahymena thermophila phagosome proteome. <span><span class="ref-journal">Eukaryot Cell. </span>2006;<span class="ref-vol">5</span>:1990–2000.</span> [<a href="/pmc/articles/PMC1694822/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1694822</span></a>] [<a href="/pubmed/17012537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17012537</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.johnson.1998.556">Johnson SE, Dahl A, Sjaastad O. Progressive pseudobulbar paresis, early choreiform movements, and later rigidity: appearance in two sets of dizygotic twins in the same family. <span><span class="ref-journal">Mov Disord. </span>1998;<span class="ref-vol">13</span>:556–62.</span> [<a href="/pubmed/9613754" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9613754</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.kageyama.2000.816">Kageyama Y, Kodama Y, Tadano M, Yamamoto S, Ichikawa K. A case of chorea-acanthocytosis with dilated cardiomyopathy and myopathy. <span><span class="ref-journal">Rinsho Shinkeigaku. </span>2000;<span class="ref-vol">40</span>:816–20.</span> [<a href="/pubmed/11218703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11218703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.kageyama.2007.1669">Kageyama Y, Matsumoto K, Ichikawa K, Ueno S, Ichiba M, Nakamura M, Sano A. A new phenotype of chorea-acanthocytosis with dilated cardiomyopathy and myopathy. <span><span class="ref-journal">Mov Disord. </span>2007;<span class="ref-vol">22</span>:1669–70.</span> [<a href="/pubmed/17516458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17516458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.kambouris.2000.445">Kambouris M, Bohlega S, Al-Tahan A, Meyer BF. Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:445–52.</span> [<a href="/pmc/articles/PMC1288097/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288097</span></a>] [<a href="/pubmed/10677304" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10677304</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.kaul.2013.169">Kaul B, Goyal V, Shukla G, Srivastava A, Garg A, Bader B, Danek A, Hayflick S, Behari M. Mineral deposition on magnetic resonance imaging in chorea-acanthocytosis: a pathogenic link with pantothenate kinase-associated neurodegeneration? <span><span class="ref-journal">Neurol India. </span>2013;<span class="ref-vol">61</span>:169–70.</span> [<a href="/pubmed/23644319" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23644319</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.kihara.2002.42">Kihara M, Nakashima H, Taki M, Takahashi M, Kawamura Y. A case of chorea-acanthocytosis with dysautonomia; quantitative autonomic deficits using CASS. <span><span class="ref-journal">Auton Neurosci. </span>2002;<span class="ref-vol">97</span>:42–4.</span> [<a href="/pubmed/12036185" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12036185</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.kolehmainen.2003.1359">Kolehmainen J, Black GC, Saarinen A, Chandler K, Clayton-Smith J, Traskelin AL, Perveen R, Kivitie-Kallio S, Norio R, Warburg M, Fryns JP, de la Chapelle A, Lehesjoki AE. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:1359–69.</span> [<a href="/pmc/articles/PMC1180298/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180298</span></a>] [<a href="/pubmed/12730828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12730828</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.kurano.2006.438">Kurano Y, Nakamura M, Ichiba M, Matsuda M, Mizuno E, Kato M, Izumo S, Sano A. Chorein deficiency leads to upregulation of gephyrin and GABAA receptor. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2006;<span class="ref-vol">351</span>:438–42.</span> [<a href="/pubmed/17070500" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17070500</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.kutcher.1999.187">Kutcher JS, Kahn MJ, Andersson HC, Foundas AL. Neuroacanthocytosis masquerading as Huntington's disease: CT/MRI findings. <span><span class="ref-journal">J Neuroimaging. </span>1999;<span class="ref-vol">9</span>:187–9.</span> [<a href="/pubmed/10436764" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10436764</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.lee.2011.321">Lee JH, Lee SM, Baik SK. Demonstration of striatopallidal iron deposition in chorea-acanthocytosis by susceptibility-weighted imaging. <span><span class="ref-journal">J Neurol. </span>2011;<span class="ref-vol">258</span>:321–2.</span> [<a href="/pubmed/20798951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20798951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.lesage.2016.500">Lesage S, Drouet V, Majounie E, Deramecourt V, Jacoupy M, Nicolas A, Cormier-Dequaire F, Hassoun SM, Pujol C, Ciura S, Erpapazoglou Z, Usenko T, Maurage CA, Sahbatou M, Liebau S, Ding J, Bilgic B, Emre M, Erginel-Unaltuna N, Guven G, Tison F, Tranchant C, Vidailhet M, Corvol JC, Krack P, Leutenegger AL, Nalls MA, Hernandez DG, Heutink P, Gibbs JR, Hardy J, Wood NW, Gasser T, Durr A, Deleuze JF, Tazir M, Dest&#x000e9;e A, Lohmann E, Kabashi E, Singleton A, Corti O, Brice A, et al.  Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/parkin-dependent mitophagy. <span><span class="ref-journal">Am J Hum Genet. </span>2016;<span class="ref-vol">98</span>:500–13.</span> [<a href="/pmc/articles/PMC4800038/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4800038</span></a>] [<a href="/pubmed/26942284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26942284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.levine.1968.403">Levine IM, Estes JW, Looney JM. Hereditary neurological disease with acanthocytosis. A new syndrome. <span><span class="ref-journal">Arch Neurol. </span>1968;<span class="ref-vol">19</span>:403–9.</span> [<a href="/pubmed/5677189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5677189</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.lin.2006.38">Lin FC, Wei LJ, Shih PY. Effect of levetiracetam on truncal tic in neuroacanthocytosis. <span><span class="ref-journal">Acta Neurol Taiwan. </span>2006;<span class="ref-vol">15</span>:38–42.</span> [<a href="/pubmed/16599284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16599284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.liu.2012.s57">Liu J, Arzberger T, Radunovic A, Pohl U, Mohiddin S, Kageyama Y, Kiehl R, Lang T, Schoser B, Kretzschmar HA, Danek A, Bader B. Neuromuscular findings in chorea-acanthocythosis. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2012;<span class="ref-vol">18</span>:S57.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.lossos.2005.611">Lossos A, Dobson-Stone C, Monaco AP, Soffer D, Rahamim E, Newman JP, Mohiddin S, Fananapazir L, Lerer I, Linetsky E, Reches A, Argov Z, Abramsky O, Gadoth N, Sadeh M, Gomori JM, Boher M, Meiner V. Early clinical heterogeneity in choreoacanthocytosis. <span><span class="ref-journal">Arch Neurol. </span>2005;<span class="ref-vol">62</span>:611–4.</span> [<a href="/pubmed/15824261" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15824261</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.margolis.2004.670">Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, Mysore J, Shimohata T, Tsuji S, Potter N, Nakaso K, Adachi Y, Nakashima K, Bird T, Krause A, Greenstein P. Huntington's Disease-like 2 (HDL2) in North America and Japan. <span><span class="ref-journal">Ann Neurol. </span>2004;<span class="ref-vol">56</span>:670–4.</span> [<a href="/pubmed/15468075" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15468075</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.marson.2003.188">Marson AM, Bucciantini E, Gentile E, Geda C. Neuroacanthocytosis: clinical, radiological, and neurophysiological findings in an Italian family. <span><span class="ref-journal">Neurol Sci. </span>2003;<span class="ref-vol">24</span>:188–9.</span> [<a href="/pubmed/14598080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14598080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.melone.2002.841">Melone MA, Di Fede G, Peluso G, Lus G, Di Iorio G, Sampaolo S, Capasso A, Gentile V, Cotrufo R. Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2002;<span class="ref-vol">61</span>:841–8.</span> [<a href="/pubmed/12387450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12387450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.miki.2010.271">Miki Y, Nishie M, Ichiba M, Nakamura M, Mori F, Ogawa M, Kaimori M, Sano A, Wakabayashi K. Chorea-acanthocytosis with upper motor neuron degeneration and 3419_3420 delCA and 3970_3973 delAGTC VPS13A mutations. <span><span class="ref-journal">Acta Neuropathol. </span>2010;<span class="ref-vol">119</span>:271–3.</span> [<a href="/pubmed/19949804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19949804</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.milanez.2001.1242">Milanez T, Kobal J, Grmek M, Fettich J. 99mTc HMPAO brain perfusion in family with chorea-acanthocytosis. <span><span class="ref-journal">Eur J Nuc Med. </span>2001;<span class="ref-vol">28</span>:1242.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.miquel.2013.e79241">Miquel M, Spampinato U, Latxague C, Aviles-Olmos I, Bader B, Bertram K, Bhatia K, Burbaud P, Burghaus L, Cho JW, Cuny E, Danek A, Foltynie T, Garcia Ruiz PJ, Gimenez-Roldan S, Guehl D, Guridi J, Hariz M, Jarman P, Kefalopoulou ZM, Limousin P, Lipsman N, Lozano AM, Moro E, Ngy D, Rodriguez-Oroz MC, Shang H, Shin H, Walker RH, Yokochi F, Zrinzo L, Tison F. Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e79241.</span> [<a href="/pmc/articles/PMC3818425/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3818425</span></a>] [<a href="/pubmed/24223913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24223913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.mohiddin.2004">Mohiddin SA, Fananapazir L. Cardiac involvement in the neuroacanthocytosis syndromes. In: Danek A, ed. <em>Neuroacanthocytosis Syndromes</em>. Dordrecht, The Netherlands: Springer; 2004:139-52.</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.m_llervahl.2007.1081">M&#x000fc;ller-Vahl KR, Berding G, Emrich HM, Peschel T. Chorea-acanthocytosis in monozygotic twins: clinical findings and neuropathological changes as detected by diffusion tensor imaging, FDG-PET and (123)I-beta-CIT-SPECT. <span><span class="ref-journal">J Neurol. </span>2007;<span class="ref-vol">254</span>:1081–8.</span> [<a href="/pubmed/17294064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17294064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.neutel.2012.293">Neutel D, Miltenberger-Miltenyi G, Silva I, de Carvalho M. Chorea-acanthocytosis presenting as motor neuron disease. <span><span class="ref-journal">Muscle Nerve. </span>2012;<span class="ref-vol">45</span>:293–5.</span> [<a href="/pubmed/22246890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22246890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.ogawa.2013.913">Ogawa I, Saigoh K, Hirano M, Mtsui Y, Sugioka K, Takahashi J, Shimomura Y, Tani Y, Nakamura Y, Kusunoki S. Ophthalmologic involvement in Japanese siblings with chorea-acanthocytosis caused by a novel chorein mutation. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2013;<span class="ref-vol">19</span>:913–5.</span> [<a href="/pubmed/23746940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23746940</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.paisanruiz.2009.19">Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, Hardy J, Houlden H, Singleton A, Schneider SA. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. <span><span class="ref-journal">Ann Neurol. </span>2009;<span class="ref-vol">65</span>:19–23.</span> [<a href="/pubmed/18570303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18570303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.park.2012.3004">Park JS, Neiman AM. VPS13 regulates membrane morphogenesis during sporulation in Saccharomyces cerevisiae. <span><span class="ref-journal">J Cell Sci. </span>2012;<span class="ref-vol">125</span>:3004–11.</span> [<a href="/pmc/articles/PMC3434806/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3434806</span></a>] [<a href="/pubmed/22442115" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22442115</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.pellecchia.2005.1810">Pellecchia MT, Valente EM, Cif L, Salvi S, Albanese A, Scarano V, Bonuccelli U, Bentivoglio AR, D'Amico A, Marelli C, Di Giorgio A, Coubes P, Barone P, Dallapiccola B. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:1810–2.</span> [<a href="/pubmed/15911822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15911822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.rampoldi.2001.119">Rampoldi L, Dobson-Stone C, Rubio JP, Danek A, Chalmers RM, Wood NW, Verellen C, Ferrer X, Malandrini A, Fabrizi GM, Brown R, Vance J, Pericak-Vance M, Rudolf G, Carre S, Alonso E, Manfredi M, Nemeth AH, Monaco AP. A conserved sorting-associated protein is mutant in chorea-acanthocytosis. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:119–20.</span> [<a href="/pubmed/11381253" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11381253</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.rampoldi.2002.475">Rampoldi L, Danek A, Monaco AP. Clinical features and molecular bases of neuroacanthocytosis. <span><span class="ref-journal">J Mol Med. </span>2002;<span class="ref-vol">80</span>:475–91.</span> [<a href="/pubmed/12185448" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12185448</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.richfield.2002.327">Richfield EK, Vonsattel JP, MacDonald ME, Sun Z, Deng YP, Reiner A. Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease. <span><span class="ref-journal">Mov Disord. </span>2002;<span class="ref-vol">17</span>:327–32.</span> [<a href="/pubmed/11921119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11921119</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.ross.1997.305">Ross CA, Margolis RL, Rosenblatt A, Ranen NG, Becher MW, Aylward E. Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). <span><span class="ref-journal">Medicine (Baltimore). </span>1997;<span class="ref-vol">76</span>:305–38.</span> [<a href="/pubmed/9352736" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9352736</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.ruiz.2009.1546">Ruiz PJ, Ayerbe J, Bader B, Danek A, Sainz MJ, Cabo I, Frech FA. Deep brain stimulation in chorea acanthocytosis. <span><span class="ref-journal">Mov Disord. </span>2009;<span class="ref-vol">24</span>:1546–7.</span> [<a href="/pubmed/19425062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19425062</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.saiki.2004.833">Saiki S, Hirose G, Sakai K, Matsunari I, Higashi K, Saiki M, Kataoka S, Hori A, Shimazaki K. Chorea-acanthocytosis associated with Tourettism. <span><span class="ref-journal">Mov Disord. </span>2004;<span class="ref-vol">19</span>:833–6.</span> [<a href="/pubmed/15254946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15254946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.saiki.2003.1614">Saiki S, Sakai K, Kitagawa Y, Saiki M, Kataoka S, Hirose G. Mutation in the CHAC gene in a family of autosomal dominant chorea-acanthocytosis. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:1614–6.</span> [<a href="/pubmed/14663054" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14663054</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.saiki.2007.848">Saiki S, Sakai K, Murata KY, Saiki M, Nakanishi M, Kitagawa Y, Kaito M, Gondo Y, Kumamoto T, Matsui M, Hattori N, Hirose G. Primary skeletal muscle involvement in chorea-acanthocytosis. <span><span class="ref-journal">Mov Disord. </span>2007;<span class="ref-vol">22</span>:848–52.</span> [<a href="/pubmed/17345646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17345646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.samaranayake.2011.1207">Samaranayake HS, Cowan AE, Klobutcher LA. Vacuolar protein sorting protein 13A, TtVPS13A, localizes to the tetrahymena thermophila phagosome membrane and is required for efficient phagocytosis. <span><span class="ref-journal">Eukaryot Cell. </span>2011;<span class="ref-vol">10</span>:1207–18.</span> [<a href="/pmc/articles/PMC3187053/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3187053</span></a>] [<a href="/pubmed/21764909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21764909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.saxena.2010.142">Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, Kao WH, Li M, Glazer NL, Manning AK, Luan J, Stringham HM, Prokopenko I, Johnson T, Grarup N, Boesgaard TW, Lecoeur C, Shrader P, O'Connell J, Ingelsson E, Couper DJ, Rice K, Song K, Andreasen CH, Dina C, Kottgen A, Le Bacquer O, Pattou F, Taneera J, Steinthorsdottir V, Rybin D, Ardlie K, Sampson M, Qi L, van Hoek M, Weedon MN, Aulchenko YS, Voight BF, Grallert H, Balkau B, Bergman RN, Bielinski SJ, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Bottcher Y, Brunner E, Buchanan TA, Bumpstead SJ, Cavalcanti-Proenca C, Charpentier G, Chen YD, Chines PS, Collins FS, Cornelis M, Crawford GJ, Delplanque J, Doney A, Egan JM, Erdos MR, Firmann M, Forouhi NG, Fox CS, Goodarzi MO, Graessler J, Hingorani A, Isomaa B, Jorgensen T, Kivimaki M, Kovacs P, Krohn K, Kumari M, Lauritzen T, Levy-Marchal C, Mayor V, McAteer JB, Meyre D, Mitchell BD, Mohlke KL, Morken MA, Narisu N, Palmer CN, Pakyz R, Pascoe L, Payne F, Pearson D, Rathmann W, Sandbaek A, Sayer AA, Scott LJ, Sharp SJ, Sijbrands E, Singleton A, Siscovick DS, Smith NL, Sparso T, Swift AJ, Syddall H, Thorleifsson G, Tonjes A, Tuomi T, Tuomilehto J, Valle TT, Waeber G, Walley A, Waterworth DM, Zeggini E, Zhao JH, Illig T, Wichmann HE, Wilson JF, van Duijn C, Hu FB, Morris AD, Frayling TM, Hattersley AT, Thorsteinsdottir U, Stefansson K, Nilsson P, Syvanen AC, Shuldiner AR, Walker M, Bornstein SR, Schwarz P, Williams GH, Nathan DM, Kuusisto J, Laakso M, Cooper C, Marmot M, Ferrucci L, Mooser V, Stumvoll M, Loos RJ, Altshuler D, Psaty BM, Rotter JI, Boerwinkle E, Hansen T, Pedersen O, Florez JC, McCarthy MI, Boehnke M, Barroso I, Sladek R, Froguel P, Meigs JB, Groop L, Wareham NJ, Watanabe RM. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:142–8.</span> [<a href="/pmc/articles/PMC2922003/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2922003</span></a>] [<a href="/pubmed/20081857" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20081857</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.scheid.2009.1419">Scheid R, Bader B, Ott DV, Merkenschlager A, Danek A. Development of mesial temporal lobe epilepsy in chorea-acanthocytosis. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:1419–22.</span> [<a href="/pubmed/19858465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19858465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.schmidt.2013.2799">Schmidt EM, Schmid E, Munzer P, Hermann A, Eyrich AK, Russo A, Walker B, Gu S, vom Hagen JM, Faggio C, Schaller M, Foller M, Schols L, Gawaz M, Borst O, Storch A, Stournaras C, Lang F. Chorein sensitivity of cytoskeletal organization and degranulation of platelets. <span><span class="ref-journal">FASEB J. </span>2013;<span class="ref-vol">27</span>:2799–806.</span> [<a href="/pubmed/23568775" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23568775</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.schneider.2006.940">Schneider SA, Aggarwal A, Bhatt M, Dupont E, Tisch S, Limousin P, Lee P, Quinn N, Bhatia KP. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:940–3.</span> [<a href="/pubmed/17000958" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17000958</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.schneider.2010.1487">Schneider SA, Lang AE, Moro E, Bader B, Danek A, Bhatia KP. Characteristic head drops and axial extension in advanced chorea-acanthocytosis. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:1487–91.</span> [<a href="/pubmed/20544815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20544815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.seong.2018.1075">Seong E, Insolera R, Dulovic M, Kamsteeg EJ, Trinh J, Br&#x000fc;ggemann N, Sandford E, Li S, Ozel AB, Li JZ, Jewett T, Kievit AJA, M&#x000fc;nchau A, Shakkottai V, Klein C, Collins CA, Lohmann K, van de Warrenburg BP, Burmeister M. Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects. <span><span class="ref-journal">Ann Neurol. </span>2018;<span class="ref-vol">83</span>:1075–88.</span> [<a href="/pmc/articles/PMC6105379/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6105379</span></a>] [<a href="/pubmed/29604224" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29604224</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.shin.2012.273">Shin H, Ki CS, Cho AR, Lee JI, Ahn JY, Lee JH, Cho JW. Globus pallidus interna deep brain stimulation improves chorea and functional status in a patient with chorea-acanthocytosis. <span><span class="ref-journal">Stereotact Funct Neurosurg. </span>2012;<span class="ref-vol">90</span>:273–7.</span> [<a href="/pubmed/22777538" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22777538</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.shimo.2011.196">Shimo H, Nakamura M, Tomiyasu A, Ichiba M, Ueno S, Sano A. Comprehensive analysis of the genes responsible for neuroacanthocytosis in mood disorder and schizophrenia. <span><span class="ref-journal">Neurosci Res. </span>2011;<span class="ref-vol">69</span>:196–202.</span> [<a href="/pubmed/21145924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21145924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.shiokawa.2013.96">Shiokawa N, Nakamura M, Sameshima M, Deguchi A, Hayashi T, Sasaki N, Sano A. Chorein, the protein responsible for chorea-acanthocytosis, interacts with beta-adducin and beta-actin. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2013;<span class="ref-vol">441</span>:96–101.</span> [<a href="/pubmed/24129186" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24129186</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.sibon.2004.856">Sibon I, Ghorayeb I, Arne P, Tison F. Distressing belching and neuroacanthocytosis. <span><span class="ref-journal">Mov Disord. </span>2004;<span class="ref-vol">19</span>:856–9.</span> [<a href="/pubmed/15254955" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15254955</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.siegl.2013.e76715">Siegl C, Hamminger P, Jank H, Ahting U, Bader B, Danek A, Gregory A, Hartig M, Hayflick S, Hermann A, Prokisch H, Sammler EM, Yapici Z, Prohaska R, Salzer U. Alterations of red cell membrane properties in Neuroacanthocytosis. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e76715.</span> [<a href="/pmc/articles/PMC3789665/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3789665</span></a>] [<a href="/pubmed/24098554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24098554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.sokolov.2012.40">Sokolov E, Schneider SA, Bain PG. Chorea-acanthocytosis. <span><span class="ref-journal">Pract Neurol. </span>2012;<span class="ref-vol">12</span>:40–3.</span> [<a href="/pubmed/22258171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22258171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.sorrentino.1999.175">Sorrentino G, De Renzo A, Miniello S, Nori O, Bonavita V. Late appearance of acanthocytes during the course of chorea-acanthocytosis. <span><span class="ref-journal">J Neurol Sci. </span>1999;<span class="ref-vol">163</span>:175–8.</span> [<a href="/pubmed/10371080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10371080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.stafford.2013">Stafford GH, Howard RS, Lavelle J (2013) The management of osteoarthritis in movement disorders: a case discussion. Tremor Other Hyperkinet Mov (N Y). 3. pii: tre-03-153-3642-4. [<a href="/pmc/articles/PMC3708351/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3708351</span></a>] [<a href="/pubmed/23858393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23858393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.storch.2005.84">Storch A, Kornhass M, Schwarz J. Testing for acanthocytosis A prospective reader-blinded study in movement disorder patients. <span><span class="ref-journal">J Neurol. </span>2005;<span class="ref-vol">252</span>:84–90.</span> [<a href="/pubmed/15654559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15654559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.strawbridge.2011.2624">Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, Rybin D, Petrie JR, Travers ME, Bouatia-Naji N, Dimas AS, Nica A, Wheeler E, Chen H, Voight BF, Taneera J, Kanoni S, Peden JF, Turrini F, Gustafsson S, Zabena C, Almgren P, Barker DJ, Barnes D, Dennison EM, Eriksson JG, Eriksson P, Eury E, Folkersen L, Fox CS, Frayling TM, Goel A, Gu HF, Horikoshi M, Isomaa B, Jackson AU, Jameson KA, Kajantie E, Kerr-Conte J, Kuulasmaa T, Kuusisto J, Loos RJ, Luan J, Makrilakis K, Manning AK, Martinez-Larrad MT, Narisu N, Nastase Mannila M, Ohrvik J, Osmond C, Pascoe L, Payne F, Sayer AA, Sennblad B, Silveira A, Stancakova A, Stirrups K, Swift AJ, Syvanen AC, Tuomi T, van 't Hooft FM, Walker M, Weedon MN, Xie W, Zethelius B, Ongen H, Malarstig A, Hopewell JC, Saleheen D, Chambers J, Parish S, Danesh J, Kooner J, Ostenson CG, Lind L, Cooper CC, Serrano-Rios M, Ferrannini E, Forsen TJ, Clarke R, Franzosi MG, Seedorf U, Watkins H, Froguel P, Johnson P, Deloukas P, Collins FS, Laakso M, Dermitzakis ET, Boehnke M, McCarthy MI, Wareham NJ, Groop L, Pattou F, Gloyn AL, Dedoussis GV, Lyssenko V, Meigs JB, Barroso I, Watanabe RM, Ingelsson E, Langenberg C, Hamsten A, Florez JC. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. <span><span class="ref-journal">Diabetes. </span>2011;<span class="ref-vol">60</span>:2624–34.</span> [<a href="/pmc/articles/PMC3178302/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3178302</span></a>] [<a href="/pubmed/21873549" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21873549</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.tamura.2005.516">Tamura Y, Matsui K, Yaguchi H, Hashimoto M, Inoue K. Nemaline rods in chorea-acanthocytosis. <span><span class="ref-journal">Muscle Nerve. </span>2005;<span class="ref-vol">31</span>:516–9.</span> [<a href="/pubmed/15660376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15660376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.terada.1999.25">Terada N, Fujii Y, Ueda H, Kato Y, Baba T, Hayashi R, Ohno S. Ultrastructural changes of erythrocyte membrane skeletons in chorea- acanthocytosis and McLeod syndrome revealed by the quick-freezing and deep-etching method. <span><span class="ref-journal">Acta Haematol. </span>1999;<span class="ref-vol">101</span>:25–31.</span> [<a href="/pubmed/10085435" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10085435</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.tiftikcioglu.2006.46">Tiftikcioglu BI, Dericioglu N, Saygi S. Focal seizures originating from the left temporal lobe in a case with chorea-acanthocytosis. <span><span class="ref-journal">Clin EEG Neurosci. </span>2006;<span class="ref-vol">37</span>:46–9.</span> [<a href="/pubmed/16475485" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16475485</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.tomemori.2005.759">Tomemori Y, Ichiba M, Kusumoto A, Mizuno E, Sato D, Muroya S, Nakamura M, Kawaguchi H, Yoshida H, Ueno S, Nakao K, Nakamura K, Aiba A, Katsuki M, Sano A. A gene-targeted mouse model for chorea-acanthocytosis. <span><span class="ref-journal">J Neurochem. </span>2005;<span class="ref-vol">92</span>:759–66.</span> [<a href="/pubmed/15686477" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15686477</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.tomiyasu.2011.620">Tomiyasu A, Nakamura M, Ichiba M, Ueno S, Saiki S, Morimoto M, Kobal J, Kageyama Y, Inui T, Wakabayashi K, Yamada T, Kanemori Y, Jung HH, Tanaka H, Orimo S, Afawi Z, Blatt I, Aasly J, Ujike H, Babovic-Vuksanovic D, Josephs KA, Tohge R, Rodrigues GR, Dupr&#x000e9; N, Yamada H, Yokochi F, Kotschet K, Takei T, Rudzi&#x00144;ska M, Szczudlik A, Penco S, Fujiwara M, Tojo K, Sano A. Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2011;<span class="ref-vol">156B</span>:620–31.</span> [<a href="/pubmed/21598378" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21598378</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.ueno.2001.121">Ueno S, Maruki Y, Nakamura M, Tomemori Y, Kamae K, Tanabe H, Yamashita Y, Matsuda S, Kaneko S, Sano A. The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:121–2.</span> [<a href="/pubmed/11381254" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11381254</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.velayosbaeza.2011.1330">Velayos-Baeza A, Holinski-Feder E, Neitzel B, Bader B, Critchley EM, Monaco AP, Danek A, Walker RH. Chorea-acanthocytosis genotype in the original critchley kentucky neuroacanthocytosis kindred. <span><span class="ref-journal">Arch Neurol. </span>2011;<span class="ref-vol">68</span>:1330–3.</span> [<a href="/pmc/articles/PMC4615612/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4615612</span></a>] [<a href="/pubmed/21987550" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21987550</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.velayosbaeza.2004.536">Velayos-Baeza A, Vettori A, Copley RR, Dobson-Stone C, Monaco AP. Analysis of the human VPS13 gene family. <span><span class="ref-journal">Genomics. </span>2004;<span class="ref-vol">84</span>:536–49.</span> [<a href="/pubmed/15498460" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15498460</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.velayosbaeza.2008">Velayos-Baeza A, Levecque C, Dobson-Stone C, Monaco AP. The function of chorein. In: Walker RH, Saiki S, Danek A, eds. <em>Neuroacanthocytosis Syndromes II</em>. Berlin, Germany: Springer-Verlag; 2008:87-105.</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.vital.2002.77">Vital A, Bouillot S, Burbaud P, Ferrer X, Vital C. Chorea-acanthocytosis: neuropathology of brain and peripheral nerve. <span><span class="ref-journal">Clin Neuropathol. </span>2002;<span class="ref-vol">21</span>:77–81.</span> [<a href="/pubmed/12005256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12005256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.vonsattel.1998.369">Vonsattel JP, DiFiglia M. Huntington disease. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>1998;<span class="ref-vol">57</span>:369–84.</span> [<a href="/pubmed/9596408" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9596408</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.walker.2006.2268">Walker RH, Liu Q, Ichiba M, Muroya S, Nakamura M, Sano A, Kennedy CA, Sclar G. Self-mutilation in chorea-acanthocytosis: Manifestation of movement disorder or psychopathology? <span><span class="ref-journal">Mov Disord. </span>2006;<span class="ref-vol">21</span>:2268–9.</span> [<a href="/pubmed/17044067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17044067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.walker.2003.1002">Walker RH, Rasmussen A, Rudnicki D, Holmes SE, Alonso E, Matsuura T, Ashizawa T, Davidoff-Feldman B, Margolis RL. Huntington's disease-like 2 can present as chorea-acanthocytosis. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:1002–4.</span> [<a href="/pubmed/14557581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14557581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.walker.2012a.539">Walker RH, Schulz VP, Tikhonova IR, Mahajan MC, Mane S, Arroyo Muniz M, Gallagher PG. Genetic diagnosis of neuroacanthocytosis disorders using exome sequencing. <span><span class="ref-journal">Mov Disord. </span>2012a;<span class="ref-vol">27</span>:539–43.</span> [<a href="/pubmed/22038564" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22038564</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.walker.2012b.198">Walker RH, Velayos-Baeza A, Bader B, Danek A, Saiki S. Mutation in the CHAC gene in a family of autosomal dominant chorea-acanthocytosis. <span><span class="ref-journal">Neurology. </span>2012b;<span class="ref-vol">79</span>:198–9.</span> [<a href="/pubmed/22778235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22778235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.walterfang.2011a.1275">Walterfang M, Evans A, Looi JC, Jung HH, Danek A, Walker RH, Velakoulis D. The neuropsychiatry of neuroacanthocytosis syndromes. <span><span class="ref-journal">Neurosci Biobehav Rev. </span>2011a;<span class="ref-vol">35</span>:1275–83.</span> [<a href="/pubmed/21237198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21237198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.walterfang.2011b.29">Walterfang M, Looi JC, Styner M, Walker RH, Danek A, Niethammer M, Evans A, Kotschet K, Rodrigues GR, Hughes A, Velakoulis D. Shape alterations in the striatum in chorea-acanthocytosis. <span><span class="ref-journal">Psychiatry Res. </span>2011b;<span class="ref-vol">192</span>:29–36.</span> [<a href="/pmc/articles/PMC3324182/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3324182</span></a>] [<a href="/pubmed/21377843" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21377843</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.walterfang.2008.422">Walterfang M, Yucel M, Walker R, Evans A, Bader B, Ng A, Danek A, Mocellin R, Velakoulis D. Adolescent obsessive compulsive disorder heralding chorea-acanthocytosis. <span><span class="ref-journal">Mov Disord. </span>2008;<span class="ref-vol">23</span>:422–5.</span> [<a href="/pubmed/18058950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18058950</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.wihl.2001.572">Wihl G, Volkmann J, Allert N, Lehrke R, Sturm V, Freund HJ. Deep brain stimulation of the internal pallidum did not improve chorea in a patient with neuro-acanthocytosis. <span><span class="ref-journal">Mov Disord. </span>2001;<span class="ref-vol">16</span>:572–5.</span> [<a href="/pubmed/11391763" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11391763</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.xiang.1998.1431">Xiang F, Almqvist EW, Huq M, Lundin A, Hayden MR, Edstrom L, Anvret M, Zhang Z. A Huntington disease-like neurodegenerative disorder maps to chromosome 20p. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:1431–8.</span> [<a href="/pmc/articles/PMC1377554/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377554</span></a>] [<a href="/pubmed/9792871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9792871</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="chac.REF.xu.2004.299">Xu X, Pin S, Gathinji M, Fuchs R, Harris ZL. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2004;<span class="ref-vol">1012</span>:299–305.</span> [<a href="/pubmed/15105274" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15105274</span></a>]</div></li></ul></div></div><div id="chac.Chapter_Notes"><h2 id="_chac_Chapter_Notes_">Chapter Notes</h2><div id="chac.Author_Notes"><h3>Author Notes</h3><p>A Danek and B Bader offer chorein western blot testing on a research basis. Please email Adrian.Danek@med.uni-muenchen.de or download instructions for blood sampling and shipping from <a href="http://www.euro-hd.net/html/na/network/docs" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euro-hd.net/html/na/network/docs</a>.</p><p>The authorship for the different versions of this review has been as follows:</p><ul><li class="half_rhythm"><div><b>Original posting (2002).</b> Luca Rampoldi, Carol Dobson-Stone, Adrian Danek, Anthony P Monaco</div></li><li class="half_rhythm"><div><b>First update (2004).</b> Carol Dobson-Stone, Luca Rampoldi, Antonio Velayos Baeza, Adrian Danek, Anthony P Monaco</div></li><li class="half_rhythm"><div><b>Second update (2006).</b> Carol Dobson-Stone, Luca Rampoldi, Antonio Velayos Baeza, Ruth H Walker, Adrian Danek, Anthony P Monaco</div></li><li class="half_rhythm"><div><b>Third update (2010).</b> Carol Dobson-Stone, Luca Rampoldi, Benedikt Bader, Antonio Velayos Baeza, Ruth H Walker, Adrian Danek, Anthony P Monaco</div></li><li class="half_rhythm"><div><b>Fourth update (2014).</b> Antonio Velayos Baeza, Carol Dobson-Stone, Luca Rampoldi, Benedikt Bader, Ruth H Walker, Adrian Danek, Anthony P Monaco</div></li></ul></div><div id="chac.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>18 April 2019 (avb) Revision: New information on <i>VPS13C</i> and <i>VPS13D</i></div></li><li class="half_rhythm"><div>30 January 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 August 2011 (cd) Revision: prenatal testing available clinically as listed in the GeneTests Laboratory Directory</div></li><li class="half_rhythm"><div>6 July 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 October 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 January 2005 (ad) Revision: Differential Diagnosis; Testing</div></li><li class="half_rhythm"><div>16 July 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 June 2002 (me) Review posted live</div></li><li class="half_rhythm"><div>7 March 2002 (lr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1387</span><span class="label">PMID: <a href="/pubmed/20301561" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301561</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/x-dcdp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/choroid/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1387&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1387/?report=reader">PubReader</a></li><li><a href="/books/NBK1387/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1387" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1387" style="display:none" title="Cite this Page"><div class="bk_tt">Velayos Baeza A, Dobson-Stone C, Rampoldi L, et al. Chorea-Acanthocytosis. 2002 Jun 14 [Updated 2019 Apr 18]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1387/pdf/Bookshelf_NBK1387.pdf">PDF version of this page</a> (273K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#chac.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#chac.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#chac.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#chac.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#chac.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#chac.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#chac.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#chac.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#chac.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#chac.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#chac.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23230[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">VPS13A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1460226" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1460226" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1460226" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1460226" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19497603" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">[Chorea-acanthocytosis without acanthocytes].</a><span class="source">[Rev Neurol (Paris). 2010]</span><div class="brieflinkpop offscreen_noflow">[Chorea-acanthocytosis without acanthocytes].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bayreuther C, Borg M, Ferrero-Vacher C, Chaussenot A, Lebrun C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Neurol (Paris). 2010 Jan; 166(1):100-3. Epub 2009 Jun 3.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31543803" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Efficacy of Deep Brain Stimulation in a Patient with Genetically Confirmed Chorea-Acanthocytosis.</a><span class="source">[Case Rep Neurol. 2019]</span><div class="brieflinkpop offscreen_noflow">Efficacy of Deep Brain Stimulation in a Patient with Genetically Confirmed Chorea-Acanthocytosis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Richard A, Hsu J, Baum P, Alterman R, Simon DK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Case Rep Neurol. 2019 May-Aug; 11(2):199-204. Epub 2019 Jun 26.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28446873" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Novel &lt;i&gt;VPS13A&lt;/i&gt; Gene Mutations Identified in Patients Diagnosed with Chorea-acanthocytosis (ChAc): Case Presentation and Literature Review.</a><span class="source">[Front Aging Neurosci. 2017]</span><div class="brieflinkpop offscreen_noflow">Novel &lt;i&gt;VPS13A&lt;/i&gt; Gene Mutations Identified in Patients Diagnosed with Chorea-acanthocytosis (ChAc): Case Presentation and Literature Review.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shen Y, Liu X, Long X, Han C, Wan F, Fan W, Guo X, Ma K, Guo S, Wang L, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Front Aging Neurosci. 2017; 9:95. Epub 2017 Apr 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29620515" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Progress in the Diagnosis and Management of Chorea-acanthocytosis.</a><span class="source">[Chin Med Sci J. 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Progress in the Diagnosis and Management of Chorea-acanthocytosis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Liu Y, Liu ZY, Wan XH, Guo Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Chin Med Sci J. 2018 Mar 30; 33(1):53-59. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28749637" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC6A3</i>-Related Dopamine Transporter Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC6A3</i>-Related Dopamine Transporter Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kurian MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301561" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301561" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d8675f66d18aa9a12d2">Chorea-Acanthocytosis - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Chorea-Acanthocytosis - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:31:50-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D62DFE040392100000000042A0155&amp;ncbi_session=CE8D62DFE040D851_1066SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1387%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1387&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1387/&amp;ncbi_pagename=Chorea-Acanthocytosis - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D62DFE040D851_1066SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>